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Background: Inpatient services for people with intellectual and other types of developmental disabilities
(IDD) who also have forensic or risk issues are largely provided in secure hospitals. Although this is a
health service sector with high levels of expenditure, there is limited empirical information on patient
outcomes from such services. In order for a future substantive longitudinal outcomes study in forensic IDD
services to be informed and feasible, more needs to be understood about the outcome domains that are
of relevance and importance and how they should be measured. A preliminary series of studies was
therefore undertaken.
Objectives: To synthesise evidence in relation to the outcome domains that have been researched in the
existing literature from hospital and community forensic services for people with IDD, within the broad
domains of service effectiveness, patient safety and patient experience. To identify a definitive framework
of outcome domains (and associated measures and indicators) based both on this research evidence
and on the views of patients, carers and clinicians. To synthesise the information gathered in order to
inform design of future multisite longitudinal research in the sector.
Design: Three linked studies were conducted. Stage 1 was a systematic review and evidence synthesis of
outcome domains and measures as found within the forensic IDD literature. Stage 2 was a consultation
exercise with 15 patients with IDD and six carers. Stage 3 was a modified Delphi consensus exercise with
15 clinicians and experts using the information gathered at stages 1 and 2.
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Results: At stage 1, 60 studies that researched a range of outcomes in forensic IDD services were
identified from the literature. This resulted in the construction of an initial framework of outcome domains.
The consultation with patients and carers at stage 2 added to these framework domains that related
particularly to carer experience and the level of support post discharge in the community. The Delphi
process at stage 3 confirmed the validity of the resulting framework for clinician. This survey also identified
the outcome measures preferred by clinicians and those that are currently utilised in services. Thus,
indicators of appropriate measures in some important domains were identified, although there was a
paucity of measures in other domains.
Conclusions: Together, these three linked studies led to the development of an evidence-based
framework of key outcome domains and subdomains. A provisional list of associated measures and
indicators was developed, although with the paucity of measures in some domains development of specific
indicators may be required. With further refinement this could eventually be utilised by services and
commissioners for comparative purposes, and in future empirical research on outcomes in forensic IDD
services. An outline research proposal closely linked to recent policy initiatives was proposed. Limitations of
the study include the relatively small number of carers and patients and range of experts consulted.
Future work: This would comprise a national longitudinal study tracking IDD in patients through
hospitalisation and discharge.
Study registration: This study is registered as PROSPERO CRD42015016941.
Funding: The National Institute for Health Research Health Services and Delivery Research programme.
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People with intellectual and other types of developmental disabilities (IDD) (which may include autisticspectrum disorders) exhibit differences in cognitive functioning and day-to-day living skills that start in
the developmental period. A small proportion of people with IDD can present with behaviour which
cannot be safely managed in the community, and they may be detained in a secure hospital. Such
hospitals, also called forensic hospitals or services, are high cost to the NHS, but little is known about
patient outcomes from inpatient treatment. Research therefore needs to be undertaken in this area.
This project conducted preliminary work in preparation for a wider and more in-depth future project.
We aimed to answer three questions:
1. What outcome ‘domains’ (areas) have been investigated in previous research on forensic services for
people with IDD and how have they been measured?
2. What are the outcome domains that have most importance to users of such services and to
their carers?
3. What do expert clinicians (e.g. psychologists, psychiatrists and nurses) consider are the most important
outcome domains and measures?
We attempted to answer these questions by carrying out three linked studies:
1. a summary of the evidence from previously published research
2. consultation groups with patients with IDD from secure hospitals and their carers
3. an online survey of a panel of clinical experts.
Combining evidence from the three studies, we developed detailed categories of outcome domains and
proposed ways of measuring these domains. With further refinement these could be used in future
longitudinal outcomes research in forensic IDD services.
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A small proportion of people with intellectual and other types of developmental disabilities (IDD) can
present with behaviour that contravenes the law, or that is otherwise high risk, and cannot be safely
managed in the community. These individuals typically present with a high degree of clinical complexity
and may be detained for treatment in a secure hospital under the Mental Health Act 1983 (amended
2007) (Great Britain. Mental Health Act. London: The Stationery Office; 2007). Although it is a health
service sector with high levels of expenditure, with the NHS currently funding around 1800 secure beds,
there is limited empirical information on patient outcomes from such forensic mental health services for
people with IDD. In order for a future substantive longitudinal outcomes study to be informed and
feasible, more needs to be understood about the outcome domains that are of importance and how they
should be measured. A preliminary series of studies was therefore undertaken.
Objectives
l To synthesise evidence on the outcome domains that have been investigated in existing research from
forensic services for people with IDD, in the broad domains of service effectiveness, patient safety and
patient experience.
l To identify the views of patients in forensic IDD services and their carers on the outcome domains of
most importance and relevance to them.
l To gain consensus on expert views on the outcome domains of most importance for use in future
evaluation of forensic IDD services, based on the domains identified from the existing research and
patient/carers views.
l To identify a framework of outcome domains (and potential associated measures and indicators) based
on the research evidence and on the views of patients, carers and clinicians.
l To synthesise the information gathered in order to inform the design of a future longitudinal research
project in the sector.
Methods
Three linked studies were conducted:
l Stage 1: a systematic review of the literature pertaining to a range of forensic services for people with
IDD, focusing specifically on the outcomes that have been researched. Searches of the following
databases were conducted on 1 July 2015: MEDLINE, PsycINFO, EMBASE, Allied and Complementary
Medicine, Health Management Information Consortium, the British Nursing Index and the Cumulative
Index to Nursing and Allied Health Literature from inception to May 2015. Similar outcome domains
and measures were clustered together in a qualitative synthesis.
l Stage 2: a series of consultation discussion groups with patients and carers.
l Stage 3: a modified online Delphi expert consensus process conducted over two rounds using the items
generated at stages 1 and 2.
Results
At stage 1, 60 studies that researched outcome domains in forensic IDD services (which included secure
hospital-based and community-based services) were identified from the literature. This resulted in the
construction of an initial framework of 31 outcome domains, under three superordinate domains.
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The consultation with 15 patients and six carers at stage 2 added a number of domains to this framework,
which particularly related to carer experience.
The Delphi process at stage 3 had 15 respondents at both round 1 and round 2; these were primarily
clinicians in forensic IDD services. This process highlighted support for the validity of the framework and
identified several key domains of most importance to clinicians. This survey also identified the outcome
measures or indicators preferred by clinicians and those that are utilised currently in services. Both this
survey and the systematic review identified a paucity of appropriate measures in some key domains,
particularly in relation to treatment progress.
Conclusions
Together, these three linked studies resulted in the consolidation of a framework of key outcome domains
and subdomains. It also led to a long list of provisional associated measures and indicators for these
domains. With further development, this could eventually be utilised both by services and commissioners
and in any subsequent empirical longitudinal study of forensic IDD services.
Implications for research
The policy context in IDD at the present time is of importance when future research is concerned.
The Transforming Care programme and related developments, including a national service model
associated with reduction in IDD hospital bed numbers, require that secure hospitals treating people with
IDD produce accurate and relevant outcome data, both during treatment and following discharge.
This project has reviewed previous research on outcomes and clarified what a future outcome data set
should look like. An outline research design is proposed.
Study registration
This study is registered as PROSPERO CRD42015016941.
Funding
Funding for this study was provided by the Health Services and Delivery Research programme of the
National Institute for Health Research.
SCIENTIFIC SUMMARY
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Chapter 1 Introduction and background
People with intellectual and other types of developmental disabilities (IDD), such as autistic spectrumconditions, can face challenges with both adaptive behaviour and general intellectual functioning.
As long-stay hospitals for those with IDD were closed from the 1980s onwards, forensic mental health
services specifically for those with IDD have increased. These hospital services cater either for people with
IDD who have committed criminal acts and are detained under Part III of the Mental Health Act,1 or for
those under civil sections whose violent or other challenging behaviour cannot be safely managed in the
community. Typically, such patients present with a high level of clinical complexity.
A mapping exercise in 20122 indicated that in the combined NHS and independent sector there were
2393 high, medium and low secure funded beds in 10 strategic health authorities in England, with further
access to locked and unlocked forensic rehabilitation beds. In addition, a number of specialised community
IDD services provide for those with a forensic history. Inpatient secure beds in particular are high cost,
and this is therefore a sector that involves high levels of health expenditure (estimated in 2012 to be
£350–430M a year).
Within what we shall henceforth label as the forensic intellectual and developmental disabilities (FIDD)
sector, it is notable that there is limited cross-service collation of empirical information on treatment and
service outcomes, which in turn limits the ability to measure service effectiveness.2 This area of service
delivery is particularly pertinent in the context of the Department of Health’s Transforming Care
programme,3 which aims to move care for people with IDD – including those who have offended – from
hospitals to the community with the ultimate aim of closing many hospital beds (indeed, occupied secure
beds have already reduced compared with 2012 figures).3 There is a need to be able to accurately describe
the outcomes nationally both for people treated within FIDD services and, in the longer term, those who
are discharged from FIDD services, but this is not currently undertaken in a systematic way.
The Clinical Research Group in FIDD funded by the then Mental Health Research Network branch of the
National Institute for Health Research (NIHR), which included the authors, considered the research needs in
this area in 2013. As a starting point, we know that there are no agreed areas of outcome domains or routine
measures employed in this sector. No systematic review has been published in relation to outcomes or
outcome measures from such services and, therefore, little is known about the commonality of outcome
measures across services. Neither outcome measures developed for mainstream mental health services
(explored in a systematic review by Gilbody et al.)4 nor those developed for mainstream forensic services
(identified in a systematic review by Fitzpatrick et al.,5 are necessarily appropriate for FIDD services. The current
project therefore aimed to begin to address this existing gap in knowledge by conducting a preliminary study
suitable for informing a future primary research project on FIDD service outcomes.
Research group
The research steering group comprised academic and clinical experts in the FIDD field, a systematic review
expert, a methodology expert and an ‘expert by experience’ (see Acknowledgements). The group met for
two full-day meetings during the project.
Aims of the research
The aims of the research were:
1. To systematically review empirical studies that relate to short- and long-term outcomes from FIDD
services including secure, forensic rehabilitation and community forensic services. The review aimed
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specifically to synthesise the range of outcome domains studied and to identify specific measures that
have been employed.
2. To consult a group of FIDD patients/carers regarding the outcome domains of most relevance to these
groups of stakeholders.
3. To obtain consensus on appropriate outcome domains and measures for FIDD services based on the
expert opinions of professionals and providers.
4. To synthesise the findings and develop a framework of outcomes in order to inform a large-scale
primary research project.
Overview of design
The preliminary study needed to examine the evidence from a range of perspectives and, therefore,
three stages were planned. The first study was a systematic review and evidence synthesis of outcome
domains and measures as found within the FIDD literature. The second was a consultation exercise with
FIDD patients and carers and the third was a clinician and expert modified Delphi consensus exercise.
The planned timescale of the research was short: May 2015 to February 2016.
This report
This report is divided into four further substantive chapters. Chapter 2 summarises the systematic review
and evidence synthesis, which addresses aim 1. Chapter 3 describes the patient and carer consultation,
which addresses aim 2. Chapter 4 describes the Delphi study of clinicians, which addresses aim 3.
Chapter 5 synthesises the studies and describes the direction for further research and evaluation
of services.
Note on terminology
In this report ‘outcome domains’ or ‘subdomains’ refer to specific areas of outcome. These are distinct
from outcome ‘measurements/indices’, which refer to how these domains are indexed or measured.
Thus, for example, within the patient experience superordinate domain, patient satisfaction would be an
outcome subdomain and a patient satisfaction rating scale assessment would be an outcome measure for
that domain, whereas the percentage of patients ‘very satisfied’ might be a specific indicator.
INTRODUCTION AND BACKGROUND
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Chapter 2 Stage 1: systematic literature review
of outcome domains researched in forensic
intellectual/developmental disabilities services
Research questions/objectives of the review
The objective of the current review was to identify quantitative studies that examined either short- or
long-term outcomes from FIDD service-level treatment. The review sought specifically to identify and
categorise the range and type of outcome domains examined in the literature as well as the outcome
measures and indicators used to measure these domains. The findings from the studies themselves were
therefore not of direct relevance to this review.
Review methods
Search strategy
The search strategy aimed to identify studies from a range of sources. Reports were included regardless of
publication status. Searches were conducted on 1 June 2015. The electronic databases searched were
MEDLINE, PsycINFO, EMBASE, Allied and Complementary Medicine, Health Management Information
Consortium, the British Nursing Index and the Cumulative Index to Nursing and Allied Health Literature
from inception to May 2015. A broad search strategy was employed, with intellectual disability terms
being combined with forensic terms. For terms specific to intellectual and developmental disabilities, search
terms employed were based on those used for a previous Cochrane review.6 Forensic and offender terms
search terms were adapted from a large review for the Department of Health by Duggan et al.7 The full
search terms including ‘explode’ terms, keywords and text words are in Appendix 1.
In addition, the grey literature (opengrey.eu) was searched online on the same date using the same
keywords. References of suitable studies were examined to identify additional relevant articles.
Finally, expert members of the project steering group were consulted in order to identify any key
references not retrieved by the search strategy or in press or unpublished articles and service
evaluation reports.
Inclusion and exclusion criteria
Scope
The search related to studies worldwide written in any language. When studies were written in languages
other than English, translations were obtained. The search was limited to studies from 1980 onwards,
as provision for FIDD patients was either sparse or non-existent prior to this date.
Types of studies
We included any study design, including those at the lower levels of the hierarchy of evidence. Owing to
the likely paucity of randomised or controlled studies, the search strategy was designed to capture two
primary types of quantitative study:
1. Cohort studies with follow-up. These are studies that report outcomes of intervention at the whole
service level from one point in treatment to another (e.g. from admission to present; from admission to
discharge) or post discharge, with any length of follow-up.
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2. Cross-sectional studies. We also aimed to include cross-sectional studies that reported outcomes either at
a single point or for a defined period of time during FIDD service intervention. While the primary goal of
such studies is not necessarily to evaluate outcomes from services, studies were included provided they
presented data on potential measures or indicators of outcomes. For example, the purpose of the study
might be prediction of risk, but outcome data pertaining to ‘incidents of aggression’ in the service may
be presented: this was considered to be a potential outcome domain/indicator. This type of study was
included within the review for two reasons. First, the aim of the review was to identify outcome domains
and outcome indicators appropriate for measuring the effectiveness of FIDD services; the cross-sectional
studies provided important information in this regard. Second, FIDD services often provide long-term
treatment and, therefore, what happens to patients during treatment and prior to discharge can also be
considered an indicator of effectiveness.
Participants and settings
The search strategy sought to capture studies that included data on adults (aged ≥ 18 years) with
intellectual and/or developmental disabilities who had current or previous access to specialist FIDD services.
Both male and female samples, with a range of offending histories, were included. High-, medium- and
low secure inpatient forensic health services, forensic rehabilitation services (service categories 1 and 4
as defined by the Royal College of Psychiatrists, 20132) and community FIDD services were all included.
Studies of prison and youth offending services were not considered for this review, as services specifically
for people with IDD tend not to exist in these settings. Studies of mixed FIDD and non-FIDD populations
were included provided the FIDD data were identifiable.
Intervention
The intervention of interest was at the whole service level, that is, the effect that being treated in the
service as a whole has on patients’ outcomes and how that is measured. Studies that evaluated the effects
of specific interventions (e.g. sex offender treatment) were excluded. The outcome domains and indicators/
measures of such domains were of primary interest, as opposed to the findings of the studies.
Outcomes
There are as yet no agreed outcome measures for use in FIDD services, which was a primary driver for
the review. Therefore, inclusive criteria regarding the types of outcomes of interest were adopted.
Outcomes were nevertheless broadly conceptualised as falling into the following three overarching
domains, reflecting the three key quality areas outlined by the Department of Health in the first NHS
Outcomes Framework.8
Effectiveness
This domain was conceptualised to include any factors that related to the impact of FIDD service-level
treatment on the patient, in both the long and short term.
Patient safety
In the current context, the patient safety domain was conceptualised to include outcomes related to
avoidable harm such as the extent of restrictive practices in services, and patient injury or death.
Patient experience
This domain was conceptualised to include any factors that related to the patient experience of care,
such as patient quality of life, patient satisfaction, etc.
Inclusion and exclusion criteria are summarised in Appendix 2.
Study selection
After removal of duplicates, titles and abstracts of articles were screened against the inclusion criteria. In
order to avoid false negatives, all studies that could not be shown to be outside the inclusion criteria were
initially included. The full texts of the remaining articles were screened against inclusion and exclusion
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NIHR Journals Library www.journalslibrary.nihr.ac.uk
4
criteria in order to identify appropriate articles for the review. Two reviewers (CM and NG) independently
rated each article using a screening tool developed for the purposes of the study (see Appendix 3).
Any disagreements were resolved by a third reviewer (MF).
Data extraction
The articles were subjected to data extraction using a structured form (see Appendix 3). Details regarding
the sample, design, service type, methods, outcome domains and related measures were obtained, coded
and reported. The information is presented in the form of data summary tables (see Tables 1–6).
Hierarchy of evidence
On the advice of the systematic review consultant on the project, it was decided a priori that no structured
quality assessment was to be undertaken. This decision was taken for a number of reasons. First, as noted
above, the aim of the current review was to identify the range and type of outcome domains and related
measures that have been used in FIDD services research. Its purpose was not to critique the methodology
of the studies or to draw robust conclusions about the findings. Furthermore, it was recognised the studies
were likely to be heterogeneous and there would be no single quality assessment tool that would be
appropriate for included studies. Quality or risk-of-bias ratings would not have influenced the inclusion of
studies as, arguably, a poor-quality study could nevertheless have presented outcome domains of interest
for the review. We therefore decided simply to code study design using a hierarchy of evidence. The York
Centre for Reviews and Dissemination hierarchy of evidence was considered, but it was found that
included studies were difficult to classify using that hierarchy. Instead, study designs were coded with
reference to the simpler hierarchy of evidence employed by Greenhalgh9 as follows:
1. systematic reviews and meta-analyses
2. randomised controlled trials with definitive results
3. randomised controlled trials with non-definitive results
4. cohort studies (follow participants over time)
5. case–control studies (matched control group)
6. cross-sectional surveys
7. case reports or case series.
Analysis
The broad inclusion criteria applied for the review meant that the included studies represented a wide
variety of services, study designs, outcome domains and measures. A method of content analysis10 was used
to synthesise the outcome domain types and related measures and indicators. This approach involved an
iterative process of identifying categories to capture the outcome measures reported in the studies. Using
the aforementioned three core outcome domains (effectiveness, patient safety and patient experience) as
an a priori superordinate framework, the outcome measures from all included studies were listed. A process
of refining and grouping similar subdomains together was then undertaken. This led to the construction of
a ‘framework’ to describe the outcome domains that have been studied in the literature. The number of
studies falling into each final outcome domain was also quantified.
Results of the review
Figure 1 shows the flow chart of the study selection process and details number of studies identified at
each stage. A list of the 322 excluded studies is available on request from the authors.
Sixty studies met the inclusion criteria; of these, 28 were cohort outcome studies (type 4) as described
(with follow-up from 1 to 20 years) and a further 32 were other study designs. These were primarily
cross-sectional studies (type 6) which reported service-level outcome data at one time point, with a small
number of case–control and case series designs. Some of these included studies reported overlapping
samples. Only two studies were from outside the UK. Most studies were of predominantly male or
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male-only samples; only two studies reported exclusively on female FIDD samples. Of the 60 included
studies, 83% were conducted in a variety of secure inpatient settings, and 17% in community settings.
The numbers of participants ranged from 10 to 1891.
Tables 1–6 display the included studies. As the cohort studies are the more ‘prototypical’ studies of
outcome, these are tabled separately. Thus, Tables 1–3 show the cohort studies and Tables 4–6 show
cross-sectional and other studies in each of the three superordinate domains of effectiveness, safety
and patient experience, respectively. Tables 1 and 2 cover the effectiveness studies, Tables 3 and 4 cover
safety studies and Tables 5 and 6 cover patient experience studies. Studies can therefore appear in more
than one table. The tables present data for each study: study setting; design and the hierarchy of evidence
code (1–7; see p. 16); subdomains of outcomes examined in the study, and the indicators or measures
used to measure these subdomains.
The content analysis of outcomes identified a number of subdomains within each superordinate outcome
domain. The final framework of outcome domains is described in Table 7 along with the number of
studies that reported outcomes in these domains.
Total records identified 
(n = 6586)
Records after duplicates removed; 





not relevant to the review 
(n = 4548)
Full-text articles 
assessed for eligibility 
(n = 382)
Articles excluded,
 did not meet criteria 
(n = 322)




































• Hand-search, n = 5
• Local service report, n = 3
• Grey literature, n = 9
FIGURE 1 Flow chart of study selection process.
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TABLE 1 Summary of studies presenting data on the effectiveness outcome domain (cohort studies)
Study and setting
Design (hierarchy of





64 Treatment response Level of CPA support, MHA status
and CGIS




Level security/type of placement at
discharge
Readmissions % of patients readmitted to the
same unit
Relapse in MH % of patients who experienced a
relapse in MH symptoms
Reoffending Number of patients formally
reconvicted, cautioned or who had
police contact
Offender-like behaviour Behaviour that could be classed as






138 Length of stay Mean and median number of days
Medium secure Discharged patients
Follow-up: 6 years
Discharge outcome % of positive (move to a lower
level of security) or negative
(move to higher level of security)
discharges






138 Length of stay Mean and median number of days
Medium secure Follow-up: 6 years Discharge outcome % discharged successfully (to a
lower level of security) or not





(arson vs. no arson)
30 Length of stay Discharged patients only; mean
and median days
Medium secure Follow-up: 6 years Discharge pathway % of discharged patients who
moved to either a lower or





145 Length of stay Median number of days and age
on discharge




Clinical symptoms PCL-SV pre-treatment scores
(clinician rated)




Reoffending Reconvictions at 1-, 2- and 5-year
follow-up. Categorised as serious/
violent offending (as defined by
Home Office)
Time to reoffend The difference between discharge
date and reconviction date for
subsequent offence (median)
continued
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TABLE 1 Summary of studies presenting data on the effectiveness outcome domain (cohort studies) (continued )
Study and setting
Design (hierarchy of







26 Cost Average cost saving per patient
(based on hourly rate of support)
and for the service over 3 years




Cohort study (4) 61 Clinical symptoms ABC and Mini PAS-ADD
(clinician rated)
Community Follow-up: 9.5 months
average
Treatment response Categorised treatment use and %
with history of service use
Reoffending Number of patients who
reoffended; mean number of
offences per patient




Cohort study (4) 113 Reoffending Number of patients arrested and
reconvicted and cases dropped
Community Follow-up: up to
3 years
Discharge pathway Level security/type of placement at
discharge
Discharge outcome % of referrals discharged
Prevention of inpatient
admissions
Number of patients whose




Cohort study (4) Up to 278 Length of stay Median and mean years,
calculated per episode
High secure Follow-up: 10 years Discharge pathway Level security/type of placement at
discharge
Day (1988)20 Cohort study (4) 20 Length of stay Mean number of months
Medium secure Follow-up: 3 years Treatment response Categorised as either good (settled
and co-operative), fair (continuing
lesser problems) or poor (severe
problems)
Discharge pathway % of patients discharged to
rehabilitation villa, community or
hostel
Discharge outcome Level of adjustment at follow-up,
based on personal knowledge,
hospital notes and liaison with
involved agencies
Readmission % of patients readmitted to the
same unit




Cohort study (4) 48 Length of stay Mean number of days
Medium and low
secure
Follow-up: 15 months Clinical symptoms HoNOS: change between baseline
and final rating. Quartile points
used to allow for different lengths
of stay (clinician rated)
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TABLE 1 Summary of studies presenting data on the effectiveness outcome domain (cohort studies) (continued )
Study and setting
Design (hierarchy of





145 Reoffending Home Office records; % of
patients with general and violent
offences





145 Reoffending Home Office records; % of
patients with both general and
violent offences




Cohort study (4) 35 Length of stay Mean and median months
Medium secure Discharged patients
Follow-up: up to
13 years
Treatment outcome Rated as either good (risks
reduced, safe for discharge), some
(progress made in some areas, risk
remains), none (no change) or
poor (worse than admission)
Discharge outcome % of patients discharged
Discharge pathway Level security/type of placement at
discharge and follow-up
Relapse in MH Recurrence of symptoms of illness
or challenging behaviour
Readmissions % of patients readmitted to
hospital
Offender-like behaviour Behaviour that could be
interpreted as an offence
Reoffending Number of patients reconvicted
Lindsay et al.
(2002)25
Cohort study (4) 62 Offender-like behaviour % of patients suspected of
reoffending




Cohort study (4) 184 Reoffending Number of patients with clear
evidence of reoffending
Community Follow-up: 7 years Harm reduction Decrease in the number of
incidents 2 years before referral
vs. incident data at follow-up
Lindsay et al.
(2004)27
Case series (7) 18 Reoffending Number of patients with clear
evidence of reoffending




Cohort study (4) 247 Reoffending Number of patients with clear
evidence of reoffending
Community Follow-up: 12 years Harm reduction Decrease in the number of
incidents 2 years before referral
vs. incident data at follow-up
continued
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TABLE 1 Summary of studies presenting data on the effectiveness outcome domain (cohort studies) (continued )
Study and setting
Design (hierarchy of
evidence code, p. 18) n Outcome subdomain Measure/indicator
Lindsay et al.
(2013)29
Cohort study (4) 309 Reoffending Number of patients with clear
evidence of reoffending
Community Follow-up: up to 20
years
Harm reduction Standardised service incident report
data; number of offences committed




Cohort study (4) 197 Discharge pathway Number of patients discharged
and level security/type of
placement at discharge at the
1-year and 2-year follow-upsMixed services Follow-up: 2 years
Linhorst et al.
(2003)31




Follow-up: 6 months Treatment response/
engagement










28 Reoffending % of patients who reoffended
(even if this did not lead to police
contact), determined by interview
with current care team
Length of stay Mean and median number of years
Discharge pathway % of patients in high, medium,





13 Clinical symptoms YSQ (patient rated), IPDE Screen
and PCL-SV (clinician rated):
change in mean scores
High secure Follow-up: 2 years Discharge outcome Number of patients remaining in
treatment, discharged to a medium
secure ward or transferred to
another high secure ward
Morrissey et al.
(2014)33
Cohort study (4) 70 Risk assessment HCR-20: change in mean scores
over 5 years







73 Discharge outcome % of patients who made positive
(move to a lower level of security)
or negative (the same level of
security) progress
Risk assessment HCR-20





68 Length of stay Median number of years
High secure 1. in-treatment
cohort
2. admission cohort
24 Incidents Frequency per year in the first
4 years of treatment using hospital
incident records. Mean number of
violent incidents per patient/year
Follow-up: up to
6 years
Clinical symptoms EPS-BRS (clinician rated) and
EPS-SRS (patient rated)
Discharge pathway Level security/type of placement at
discharge
Discharge outcome % of patients who moved to a
lower level of security
Readmission Number of returns from trial leave
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TABLE 1 Summary of studies presenting data on the effectiveness outcome domain (cohort studies) (continued )
Study and setting
Design (hierarchy of










Discharge outcome Number of patients discharged
Discharge pathway Level security/type of placement at
discharge
Reoffending Any criminal justice involvement





45 Length of stay Mean number of weeks
Low secure Follow-up: up to
14 years
Discharge pathway Level security/type of placement at
discharge
Discharge outcome Positive (discharged to a level of
lower security) or negative
(discharged to a level of higher
security) outcome
Incidents Collected from hospital incident
records. The number of incidents
at baseline (weeks 6–10 of stay)
was compared with the number at
the end of stay (last 4 weeks of
treatment). Frequency (total
number of incidents per month)
was adjusted for length of stay.






64 Length of stay Mean months of hospital stay
Low secure Follow-up: up to
11 years
Discharge pathway Level security/type of placement at
discharge
Discharge outcome Good (discharged to community)
or bad (not placed in a community
setting) outcome
Incidents Collected from hospital incident
records. The number of incidents
at baseline (weeks 6–10 of stay)
was compared with the number at
the end of stay (last 4 weeks of
treatment). Frequency (total
number of incidents per month)
was adjusted for length of stay
ABC, Aberrant Behaviour Checklist; BRS, Behaviour Rating Scale; CGIS, Clinical Global Impressions Scale; CPA, Care
Programme Approach; EPS-BRS, Emotional Problem Scale Behaviour Rating Scale, EPS-SRS, Emotional Problem Scale
Self-Report Inventory; HCR-20, Historical, Clinical Risk 20; HoNOS, Health of the Nation Outcome Scales; IPDE, International
Personality Disorder Examination; MH, mental health; MHA, Mental Health Act; Mini PAS-ADD, Mini Psychiatric Assessment
Schedules for Adults with Developmental Disabilities; PCL-SV, Psychopathy Checklist Screening Version; OGRS, Offender
Group Reconviction Scale; PCL-R, Psychopathy Checklist Revised; VRAG, Violence Risk Appraisal Guide; YSQ, Young
Schema Questionnaire.
Note
The sample in Alexander et al.,12,13 and Esan39 overlaps. The sample in Fitzgerald et al.22 overlaps with that of Gray et al.23
The sample in Lindsay et al.25 overlaps with that of Lindsay et al.26,28,29 The sample in Reed et al.37 overlaps with that of
Xenitidis et al.38
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TABLE 2 Summary of studies presenting data on the effectiveness outcome domain (cross-sectional studies)
Study and setting Design n Outcome subdomain Measure/indicator
Ajmal (2008)40 Cross-sectional (6) 79 Clinical symptoms GSI and RSES (patient rated)
High secure
Beer et al. (2005)41 Cross-sectional (6) 59 Placement
appropriateness
% of patients requiring a less
secure placement
Low secure Clinical symptoms SBS (clinician rated)
Beer et al. (2005)42 Cross-sectional (6) 68 Length of stay Mean number of months
Low secure Placement
appropriateness
% of patients requiring less secure
care




Cross-sectional (6) 22 Risk assessment HCR-20 median scores
Low secure Incidents Average per patient at 3-monthly
intervals. Coded for severity using
the MOAS
Median number of incidents














Cross-sectional (6) 68 Incidents Severity rated: near miss, minor,
moderate, high or very high
Medium and low
secure
16-month period Incidents/total bed-days × 100.
Average number of incidents per
100 occupied bed-days; violent/
aggressive incidents and total
incidents






114 Length of stay Mean and median months for
both discharged and in-treatment
patients
Discharge outcome Number of patients with a good
(move to a lower level of security)




Number of patients who were





Cross-sectional (6) 25 Risk assessment HCR-20 and VRAG
Medium and low
secure
Incidents Number of patients involved in an
incident in 6 months
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TABLE 2 Summary of studies presenting data on the effectiveness outcome domain (cross-sectional studies) (continued )
Study and setting Design n Outcome subdomain Measure/indicator
Hall et al. (2014)48 Cross-sectional (6) 136 Treatment needs Clinician ratings
Medium and low
secure
Security need Reference group ratings of
appropriate security level
Delayed discharge Number of patients no longer
requiring current security level,
main obstacle to progress
Length of stay Maximum and average years per
level of security
Incidents Number of patients with incident
in the past 6 months
Hogue et al.
(2007)49
Cross-sectional (6) 228 Clinical symptoms EPS-BRS (clinician rated)
High, medium, low
and community
Johnson (2012)50 Cross-sectional (6) 44 Clinical symptoms RSES and EBS (patient rated)
Medium and low
secure
Length of stay Mean number of months
Kellet et al.
(2003)51




Cross-sectional (6) 52 Offender-like behaviour % of patients suspected of
reoffending








Clinical symptoms EPS-BRS (clinician rated)
Lindsay et al.
(2010)54









5 months of data Risk assessment CuRV
Incidents Aggression defined as acts of
physical violence, aggression, force
to hurt or damage staff, peers or
environment. Included verbal
abuse. Two researchers rated each
incident as aggression present or
aggression absent. Number of
patients who were aggressive in
month 1 vs. month 5
continued
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TABLE 2 Summary of studies presenting data on the effectiveness outcome domain (cross-sectional studies) (continued )








1891 Delayed discharge % of patients who had completed
treatment but did not have any
plans to leave the service in the
next month
Incidents Average frequency with which
another patient was hurt by a
patient or staff member (per






124 Risk assessment MDT ratings per patient on risk of
physical violence (scale of 0–8)
and number of times patient had
been violent in 6 months prior to
risk assessment
Incidents Author coded each description of
incident from computerised







60 Incidents Coded as either interpersonal
physical aggression or verbal
aggression/aggression to property.
Rated as low, medium or high risk
of harm
Risk assessment Number of patients involved in an
aggressive incident
HCR-20
Clinical symptoms PCL-R and EPS-BRS (clinician rated)
O’Shea et al.
(2015)59
Cross-sectional (6) 109 Risk assessment HCR-20
Medium, low and
rehabilitation
Incidents Hospital records in 3-month
period following risk assessment
for aggression and self-harm.
Coded using Overt Aggression
Scale. Rated on severity (1–4)




Cross-sectional (6) 388 Length of stay Median number of years and % of




Delayed discharge % of patients assessed as
requiring a less secure placement
Thomas et al.
(2004)61
Cross-sectional (6) 102 Length of stay Mean and median years
High secure Delayed discharge Percentage of patients assessed as
requiring a less secure placement
and main reason for this
Treatment needs SDTN scale completed by key
worker and RC
CANFOR-Short and CANDID-
Short. Average number of needs
and unmet needs
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TABLE 2 Summary of studies presenting data on the effectiveness outcome domain (cross-sectional studies) (continued )
Study and setting Design n Outcome subdomain Measure/indicator
Uppal and
McMurran (2009)62
Cross-sectional (6) Up to
396
Incidents Hospital computerised reporting
system. Coded as per the
Department of Health:
l Category A: major incidents
(e.g. abscond, hostage taking)
l Category B: serious incidents
(e.g. serious assault involving
a weapon, attempted suicide)




l Category D: all other incidents
(minor assault and
verbal abuse)
High secure 15-month period of
incidents (IDD sample
included)
Most frequent location and time
of incident. Percentage of
incidents which were violent and
which were self-harm. Average
monthly figure generated
BSI, Brief Symptom Inventory; CANDID, Camberwell assessment of need for adults; CANFOR, Camberwell assessment of
need – forensic version; CuRV, Current Risk of Violence; EBS, Evaluative Beliefs Scale; EPS-BRS, Emotional Problem Scale
Behaviour Rating Scale; GSI, Global Symptom Inventory; HCR-20, Historical, Clinical Risk 20; HoNOS, Health of the Nation
Outcome Scales; MDT, multidisciplinary team; MHA, Mental Health Act; MOAS; Modified Overt Aggression Scale;
NAS-PI, Novaco Anger Scale – Provocation Inventory; PCL-R, Psychopathy Checklist Revised; RM-2000, Risk Matrix 2000;
RSES, Rosenberg Self-Esteem Scale; SBS, Social Behavioural Schedule; SDRS, Short Dynamic Risk Scale; SDTN, Security,
Dependency and Treatment Needs Scale; VRAG, Violence Risk Appraisal Guide.
TABLE 3 Summary of studies presenting data on the patient safety outcome domain (cohort studies)





30 Seclusion, restraint and
intensive observations









138 Seclusion, restraint and
intensive observations
Mean number of episodes per patient/
month (adjusted for length of stay)





138 Seclusion, restraint and
intensive observations
Mean and median episodes per
patient/month
Medium secure Follow-up: 4 years
Ayres and Roy
(2009)16
Case series (7) 26 Medication Case study: reduction in frequency of
use of PRN medication
Community Follow-up: up to 3 years
Butwell et al.
(2000)19
Cohort study (4) Up to
278
Death Frequency of episodes (number and
% of all patients)
High secure Follow-up: 10 years
(IDD subsample)
continued
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TABLE 4 Summary of studies presenting data on the patient safety outcome domain (cross-sectional studies)
Study and setting Design n Outcome subdomain Measure/indicator
Esan et al. (2015)39 Cross-sectional (6) 114 Medication PRN usage: mean number of
episodes (total frequency divided by
total number of months of stay to
provide an average monthly figure)
Medium and low secure (ASD vs. non-ASD) Restraint, seclusion and
intensive observations
Mansell et al. (2010)56 Cross-sectional (6) 1891 Medication PRN usage: average number of
episodes
Medium and low secure 6-month period Seclusion, restraint,
locked areas
Average number of episodes
Access to health care % of units who reported a delay
in patients accessing primary
(nurse/dentist) health care
Mason (1996)63 Cross-sectional (6) 36 Seclusion Number of patients secluded;
average number of seclusion
episodes per patient/year; reason for
seclusion and distress-related
behaviours after seclusion
High secure 12-month period
ASD, autistic spectrum disorder; PRN, pro re nata.
TABLE 3 Summary of studies presenting data on the patient safety outcome domain (cohort studies) (continued )
Study and setting Design n Outcome subdomain Measure/indicator
Morrissey and
Taylor (2014)32
Cohort study (4) 13 Seclusion Hours per patient for every 6 months
of treatment over 2 years
High secure Follow-up: 2 years
Reed et al. (2004)37 Retrospective cohort
study (4)
45 Seclusion, restraint and
relocation
Episodes at baseline (weeks 6–10 of
treatment) were compared with end
of stay (last 4 weeks of treatment)
Low secure Follow-up: up to 14 years Mean monthly rates calculated to





64 Seclusion Episodes at baseline (week 6–10 of
treatment) compared with end of
stay (last 4 weeks of treatment)
Low secure Follow-up: up to 11 years
PRN, pro re nata.
TABLE 5 Summary of studies presenting data on the patient experience outcome domain (cohort studies)
Study and setting Design n Outcome subdomain Measure/indicator
Fish and Lobley (2001)64 Cohort study (4) 20 Quality of life QoLS: change from pre to post
move
Community Follow-up: 1 year
Long et al. (2014)65 Cohort study (4) 10 Milieu EssenCes change from pre to
post move
Low secure Follow-up: 3 months Satisfaction Inpatient satisfaction
questionnaire: change from pre
to post moveFemale only
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Discussion: analysis of outcome domains and measures
Domain 1: effectiveness
A total of 53 studies (29 of which were cohort studies) presented data on at least one outcome that
measured the effectiveness of FIDD services. Twelve outcome subdomains were identified as a result of
content analysis.
TABLE 6 Summary of studies presenting data on the patient experience outcome domain (cross-sectional studies)
Study and setting Design n Outcome subdomain Measure/indicator
Langdon et al. (2006)66 Cross-sectional (6) 18 Milieu CIES read aloud to patients,
scores during treatment
Medium and low secure
Mansell et al. (2010)56





Number of patient generated
complaints per unit over
6-month period, recorded via
standardised survey
Involvement Number of patients with an
up-to-date and accessible copy
of their own care plan and
number of visitors for each
patient per unit
Steptoe et al. (2006)67 Cross-sectional (6) 28 Quality of life SOS and LEC scores during
treatment
Community
Willetts et al. (2014)68 Cross-sectional (6) 45 Milieu EssenCES scores during
treatment
Medium and low secure
CIES, Correctional Institutions Environment Scale; EssenCes, Essen Climate Evaluation Scale; LEC, Life Experience Checklist;
SOS, Significant Others Scale.
TABLE 5 Summary of studies presenting data on the patient experience outcome domain (cohort studies)
(continued )






28 Quality of life QoLS scores during treatment
Medium secure Follow-up: 4 years






Cohort study (4) 44 Quality of life PWI scores: change from pre to
post move
High secure Follow-up: up to
2 years
Satisfaction Service specific evaluation
questionnaire using a visual
Likert scale via interview
EssenCES, Essen Climate Evaluation Scale; PWI, Personal Wellbeing Index; QoLS, Quality of Life Scale.
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Length of stay
An indirect measure of effectiveness, length of hospital or service stay was one of the most commonly
reported outcome domains (22 studies; see Tables 1 and 2). Length of stay was usually reported for
discharged patients, although it is well known that this is not a comprehensive measure because of the failure
to reflect those patients who have never been discharged. Length of stay can therefore also be described
at a fixed point in time for a current hospital population, and this was reported in many of the cross-sectional
studies (e.g. Beer et al.,42 Crossland et al.,45 Esan et al.,39 Hall et al.,48 Johnson et al.,50 Lofthouse et al.,55
Perera et al.60 and Thomas et al.61). Inevitably, these data are less easy to interpret unless an admission cohort
is used (as in Morrissey et al.35) and the numbers in that cohort who are still in treatment and who have
exceeded the mean length of stay of discharged patients are reported. Length of stay was variously
reported in days,12,13 weeks, 37 months45 or years.19,35 This was calculated as either a mean or a median
measure. Reported average lengths of hospital stay ranged from 9 years in high secure conditions35 to
55 weeks in low secure conditions.38
TABLE 7 Framework of outcome domains and subdomains (stage 1)
Effectiveness Number of studies
Discharge outcome/direction of care pathway 16
Delayed discharge/current placement appropriateness 6
Length of hospital stay 22
Readmission (i.e. readmitted to the same setting) 4
Clinical symptom severity/treatment needs (clinician rated) 16
Clinical symptom severity/treatment needs (patient rated) 6
Treatment response 5
Reoffending (i.e. charges/reconvictions) 18
‘Offending-like’ behaviour (which did not result in charges) 5






Restrictive practices (restraint/relocation//intensive observations) 12
Restrictive practices (seclusion/segregation) 9





Quality of life 4
Therapeutic milieu 3
Patient experience: involvement 1
Patient experience: satisfaction/complaints 3
Total 11
BNF, British National Formulary; PRN, pro re nata.
Studies can be included in multiple domains.
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Readmission to the same or another hospital setting was clearly recorded in only four cohort studies11,20,24,35
in which there was follow-up. Only one study11 provided more detail, with the mean number of bed-days
for those readmissions being supplied. Studies usually described length of stay in the hospital under study
rather than total hospital stay (including in other settings) since first admission.
Discharge outcome/direction of care pathway/delayed discharge
A total of 16 cohort studies (see Tables 1 and 2) examined discharge outcome or direction of care pathway in
terms of the level of security of the receiving service or type of community placement (e.g. independent
living, supported living, residential accommodation). This was frequently coded as either a ‘successful’
(move to a lower level of security) or ‘unsuccessful’ (move within the same or to a higher level of security)
discharge outcome.12,13,24,34,37,38 Follow-up periods for post-discharge pathway outcome ranged from 2 years23
to 13 years11 for former inpatients and 20 years for a forensic community service.29
A further six studies reported on current placement appropriateness or delayed discharge. For example, this
was reported in terms of the percentage of patients assessed as requiring a less secure placement.38,42,48,60,61
Similarly, Mansell et al.,56 in their large cross-sectional study of 1891 patients in medium and low secure
units, reported more specifically on the percentage of patients who had ‘completed treatment but did not
have any plans to leave the service in the next month’. Reasons for delayed discharge were recorded in
around half of these studies.
In summary, discharge outcome was generally reported in relation to a fixed point in time at either
discharge from hospital or later follow-up. It is not unusual, however, for some patients to demonstrate
initial progress on discharge followed by subsequent regression, placement moves and potential
readmission. It was notable that few of the studies described these more complex pathways, which can
be common in this population, although there was some attempt by Lindsay et al.,30 in their study of
pathways to secure care, to take this into account.
Clinical symptom or severity ratings/treatment needs
Sixteen studies (see Tables 1 and 2) reported on potential outcome domains relating to clinical symptoms or
treatment needs using clinician ratings [often known as clinician-rated outcome measures (CROMs)] and six
studies used patient ratings of their symptoms/needs [often reported as patient-rated outcome measures
(PROMs)] (see Tables 1 and 2). However, of these, only two cohort studies actually reported change over
time in such symptoms during treatment in a service, through repeated measurement on the same patients
(i.e. treated clinical symptom ‘change’ as an outcome measure). Thus, Dickens et al.21 reported on change in
48 patients on the Health of the Nation Outcome Scales (HoNOS-secure) (security scales and clinical scales)
during 15 months of treatment in medium- and low secure units, finding significant reduction in severity of
symptoms over time. Morrissey et al.35 reported on change over 2–3 years on the Emotional Problem Scales
(EPS)69 as a result of treatment of 68 men in a high secure setting. Both the EPS Behaviour Rating Scale
(a CROM) and the EPS Self-Report Inventory, a patient-rated outcome measure (a PROM) designed for an
intellectual disabilities population, were employed. It is notable that Morrissey et al. is the only included
cohort study that has reported on patient-rated symptom change over time as a result of intervention at the
service level.
Relatively few additional included studies reported on patient-rated clinical outcome measures at a fixed
time point. Those studies that did so used a range of measures, which included the Young Schema
Questionnaire,32 Brief Symptoms Inventory,51 Rosenberg Self-esteem Scale,40 Novaco Anger Scale44 and the
Evaluative Beliefs Scale.50 Of these, only the Novaco Anger Scale was reported to be appropriately adapted
for IDD respondents.
Most studies reported CROMs at a fixed point in time. These measures included HoNOS-secure,21,42 EPS,49,53,58
Psychopathy Checklist Revised (PCL-R) and Psychopathy Checklist Screening Version (PCL-SV),23,32,34,53,58
International Personality Disorder Evaluation Screen,32 Clinical Global Impressions Scale,11 Aberrant Behaviour
Checklist,17 Mini Psychiatric Assessment Schedules for Adults with Developmental Disabilities17 and the Social
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Behavioural Schedule.41 Treatment needs were assessed in one study using the Camberwell Assessment
of Needs-Forensic Short Version or the equivalent intellectual disability version, Camberwell Assessment of
Needs for Adults with Developmental and Intellectual Disabilities, and a measure called the Security,
Dependency and Treatment Needs Scale.61
Treatment response
Only five studies (see Tables 1 and 2) reported on outcomes that were categorised as global ‘treatment
response’. Most of these used qualitative ratings. For example, Day20 coded responses as ‘good’ (settled and
co-operative), ‘fair’ (no serious difficulties but continuing lesser problems) or ‘poor’ (severe behaviour
problems). Similarly, Halstead et al.24 coded responses as ‘good’ (risks reduced, safe for discharge), ‘some’
(progress made in some areas, risk remains), ‘none’ (no change) or ‘poor’ (worse than admission). Only one
study11 used a psychometric measure to measure this outcome: the Clinical Global Impressions Scale. Finally,
Barron et al.17 recorded whether patients had ‘current’, ‘previous’ or ‘no’ access to particular treatments,
such as psychological therapies using standardised definitions, although they did not report the extent to
which patients had engaged in these interventions.
Reoffending/‘offending-like’ behaviour/incidents
In total, 18 studies (see Tables 1 and 2) examined formal reoffending (i.e. formal charges and convictions)
on follow-up; most commonly these were retrospective discharge cohort studies utilising official records
such as police or Ministry of Justice conviction data. The most comprehensive of these reported the
percentage of individuals with serious/violent convictions at 1-, 2- and 5-year follow-up and also examined
time to reoffend.15 Barron et al.17 reported the number of offences committed as opposed to a dichotomy.
Gray et al.23 and Fitzgerald et al.22 (using the same data set) reported on whether a conviction occurred
within 2 years of discharge and was violent or non-violent. A community forensic service study provided
more detailed data on the number of participants arrested or reconvicted or cases dropped.18 One of the
few non-UK studies reported ‘any criminal justice involvement’, which included arrest without charge
following discharge from an Australian hospital unit, arrest data being likely to be a better reflection of
offending behaviour than conviction.36 Only one linked series of studies attempted to address change in
offending behaviour as a result of treatment, comparing the number of formal incidents in the 2 years
before referral to a community FIDDs service with those in a follow-up period.26,28,29
Five studies examined and attempted to measure ‘offending-like’ behaviour in the community that had not
been officially recorded.11,13,24,25,31 This is arguably an important outcome given the frequency with which
people with IDD are not progressed through the criminal justice system.70 These outcome data were
generally based on carer report and were described with various definitions, including ‘behaviour which
could be interpreted as an offence’ or ‘suspected offending.’ Alexander et al.11 differentiated between
quasi-offending behaviour that led to police contact (but may not have ended with charges) and that
which did not. This study also attempted to identify seriousness and persistency of relapse, differentiating
between ‘regular, ongoing offending-like behaviour’ and ‘phasic’ or ‘occasional’ relapse. Because of some
reliance on carer report in this domain and the retrospective nature of follow-up, the information reported
is likely to have poor reliability.
A proxy measure of maintenance of problem behaviour is the occurrence of violent incidents during
inpatient treatment, reported in 14 studies. In general, this was recorded from electronic hospital records,
and standardised for length of stay (e.g. reported as average incidents per 100 bed-days). Some studies
coded severity or used a rating scale such as the Overt Aggression Scale.43,46 Other reports differentiated
between physical violence and verbal aggression/threats.58 However, measures of change in incident
frequency over the course of treatment in FIDD services were reported in only a small number of studies.
Xenitidis et al.38 and Reed et al.37 calculated change between a 4-week period at baseline and a 4-week
period at the end of stay. Morrissey et al.35 calculated the number of violent incidents in the first year of
high secure intervention for each patient and compared that with the number in each subsequent year in
treatment. A series of community studies26,28,29 compared the number of incidents 2 years before referral
to the service with the number of incidents during intervention and follow-up. No studies reported change
in the level of seriousness of incidents over time as an outcome measure.
STAGE 1: SYSTEMATIC LITERATURE REVIEW
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Although not a type of offending, self-harm is a form of challenging behaviour that can lead to detention
and, therefore, may be a target for behaviour change. Self-harm incidents as a service-level outcome
indicator were reported in only two studies.59,62 Neither of these studies reported change over time in
self-harm as a result of intervention at the service level.
Risk assessment
A further potential proxy measure of behaviour change as a result of service intervention is the reduction
in scores on dynamic structured risk assessment ratings over time. Twelve included studies reported data
from such measures gathered in FIDD services. Most commonly, services used the structured clinical
judgement tool the Historical, Clinical Risk 20 (HCR-20).23,33,34,43,53,54,58,59 Other studies reported on static risk
assessment measures such as the Violence Risk Appraisal Guide (VRAG),23,53,54 Risk Matrix 2000,53 Offender
Group Reconviction Scale22 and Static-99,53 although these would not have utility as outcome measures as
they would not be expected to change. The vast majority of these studies reported only cross-sectional
data and not within-patient change in such measures over time. Indeed, only one study reported change in
scores over 5 years on the clinical risk items of the HCR-20 as an outcome indicator in a FIDD service,33
despite the large number of services that are required to collect routine data on this measure.
In addition to risk assessment tools, patients were assessed for their specific security needs in three studies.
This was examined as part of the security items in the HoNOS-secure ratings (e.g. Morrissey et al.32 and
Dickens et al.21) Thomas et al.61 used the informant-rated Security, Dependency and Treatment Needs Scale
which indicated the type of environment required in terms of level of security.
Domain 2: patient safety
A total of 11 studies (see Tables 3 and 4) reported on some aspect of patient safety, which were classified
into five subdomains. Two of these subdomains related to interventions that could be perceived as
‘restrictive practices’71: the first included physical restraint or periods of increased intensive nursing
observations, and the second included seclusion/segregation in response to risky or ‘challenging’ behaviour.
These were reported either in hours or in terms of the number of episodes. In parallel with recording
numbers of violent incidents, mean rates per patient/month or year of treatment were typically reported, in
order to control for length of stay. These outcomes could arguably also be construed as an effectiveness
indicator if change in rates over time in treatment is measured. Only two studies37,38 reported on such
change in seclusion rates in a cohort with follow-up. Only one study reported on the reason for seclusion,
and on distress-related behaviours after seclusion, that is, the outcome measured had a specific emphasis
on patient safety.63
Premature death was reported in only one study, which differentiated between natural causes and
suicide.19 Physical health outcomes or access to services was reported by one study only.56 This is surprising
given the higher incidence of premature death and physical health-care problems in forensic psychiatric
populations.72 Use of pro re nata (PRN) medication, which could also be perceived as a restrictive practice,
was monitored as an outcome in three studies. The number of episodes of PRN use was recorded in two
secure service studies39,56 and via a case study demonstrating a reduction in use in a community patient.16
Domain 3: patient experience
A total of 11 of the included studies reported on four patient experience-related subdomains (see Tables 5
and 6). Four studies addressed quality of life using a number of rating scales. These included the 10-item
Personal Wellbeing Index,73 the only measure specifically designed for people with intellectual disabilities
(S Trout, personal communication). Other measures employed were the Quality of Life Questionnaire,74 used
among both a medium secure (E Marks, personal communication) and female community sample,64 and the
Life Experience Checklist67 in a community sample. When change over time in reported quality of life was
examined, this was in relation to a change of environment, that is, a service development. There were no
community studies of quality-of-life maintenance over time in discharged FIDD patients.
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Three studies addressed satisfaction with services. These related to a specific service development or move,
in a community setting,64 a low secure unit65 and a high secure unit (S Trout, personal communication).
A range of satisfaction instruments that were service specific and tailored for use with people with IDD
were used. Only one study evaluated the number of patient complaints as a service outcome measure.56
A fourth subdomain of patient experience identified from the literature was the therapeutic environment,
reported in three studies using either the Essen Climate Evaluation Scale75 (EssenCES), which was rated by
both patients and staff, or the Correctional Institutions Environment Scale.76 There was no indication that
these measures had been specifically adapted for IDD patients in any of the studies. These were typically
cross-sectional studies66,68 or evaluated a specific change in environment after 3 months.65 No identified
studies reported long-term change over time in milieu quality, although it is feasible that such measures
could be used as a repeated cross-sectional service outcome indicator. Only one community study reported
on the level of support that patients received.16
Finally, patient involvement as an outcome indicator was reported in only one study: Mansell et al.,56 in
their large study, reported the number of patients with an up-to-date and accessible copy of their care
plan. This is one of the outcomes addressed by the current Transforming Care programme care and
treatment reviews.3
Conclusions
This systematic review identified 60 studies that either examined substantive outcomes or reported on
potential outcome measures from generic treatment in forensic services for people with intellectual and
developmental disabilities. Predictably there were no case–control studies that compared FIDD services with
some other type of intervention. Around half of the included studies were cohort outcome studies that
followed up patients either during or after a period of treatment in such services. The remainder were
primarily cross-sectional studies that reported on potential outcome domains at a fixed point in time
(although these studies did not necessarily have the explicit aim of evaluating outcomes). Few studies
acknowledged the complex outcome pathways common in this clinical population and, interestingly,
none mentioned prison as an outcome destination, although this is likely to have been the outcome for
some patients.
A broad range of effectiveness outcome domains and measures was identified from the literature,
although it is evident that such domains are measured in different ways, with few consistently applied
measures other than in the realm of risk assessment. Even apparently categorical data relating to violent
incidents or offending were measured differently across studies. Significantly, very few studies examined
‘change’ in patients over their time in treatment using repeated measures of effectiveness, for example
change in incident frequency or rated risk, clinical symptoms or progression in achievement of treatment
goals. This no doubt reflects the challenges in collecting and analysing longitudinal patient linked data,
although it could also relate to the explicit exclusion of studies that evaluated specific treatment
interventions as opposed to interventions at the service level. It was notable that that very few of the
included service-level outcome studies describe details of the different components of the treatment that
patients have received, an issue which needs to be addressed in future research. Finally, there was a
relative paucity of reports on patient-rated outcome measures, particularly those relating to treatment
progress, recovery and patient experience, and to the quality of community life following discharge from
FIDD services.
It is acknowledged that the published research evidence is driven by a range of factors, including the
availability of data in services, and does not necessarily reflect the outcomes domains of importance to
clinicians, patients and carers. This is addressed in stages 2 and 3 of the project.
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Chapter 3 Stage 2: patient and carer
consultation groups
Aim
The purpose of consulting patients and carers was to incorporate their views into the framework of
outcome domains appropriate for future research on outcomes from FIDD services. It was considered
important to obtain perspectives from these different groups, as their views may differ to those of experts
in relation to which outcomes are important and relevant.
Consultation methodology
As the consultation related to future research it was construed as patient and carer involvement by the
Nottinghamshire Healthcare Foundation Trust Research Governance Group and was therefore deemed not
to require a further ethical opinion.
Three patient consultation groups were conducted in May 2015 in the context of routine patient meetings.
Patients were provided with information sheets (see Appendix 4), gave written consent to participate and
had the opportunity to withdraw at any point. Two groups were conducted in a high-security institution
(a NHS service) and one in medium-/low-security institution (an independent sector service). These groups
included three female patients, one transgender patient and 11 male patients. Seven were from low- and
medium-security institutions and eight were from high-security institutions.
Carer consultation took place in June 2015. Four carers were recruited from one hospital’s carer group and
consulted as a group, and two carers were separately recruited and interviewed as a pair. The relatives of
those consulted were in three different units at the time of consultation. Of these six carers, one was male
and five were female. Carers were provided with an information sheet, and gave written consent to
participate, and were provided with travel expenses and costs. Relatives of all carers were in low- or
medium secure FIDD care, and one was in a bespoke service within a hospital (these carers expressed a
willingness to be identifiable).
All consultation meetings were led by two members of the research team, including in all but one patient
group the project lead. An independent advocate was included in the high secure meetings.
A semistructured topic guide was employed to facilitate discussion. This focused on the outcomes that
patients and carers would consider important from a period in hospital in the short, medium and longer
term (see Appendix 5). The discussion groups ranged in duration from 1 to 1.5 hours, and relative focus
on each area depended on the response of the group. Detailed notes or full transcription of consultation
meetings was undertaken depending on security restrictions. Interview data were broadly content analysed
by the lead researcher according to the three main domains (effectiveness, safety and patient and carer
experience), with the initial framework from the stage 1 systematic review used as a starting point
(see Table 7). Although a formal qualitative data analysis approach was not undertaken, comments and
discussion points were listed under the domain and subdomains already identified. Where appropriate,
new subthemes were identified from the consultation data.
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Findings
This section of the report summarises the content from the consultation groups, under the three
superordinate domain headings. Not all of the original subdomains were commented on in detail in the
interviews, and subdomains are therefore combined in the discussion. However, a number of additional
outcome subdomains which had not included in the initial framework were identified. Box 1 therefore
represents the framework from stage 1 amended to incorporate additional themes generated from
patients and carers.
Quotations are included for illustrative purposes. Quotations are referenced only as patient or carer,
as linking quotations can lead to potential identification of individuals. In some instances the gender
reference in the quotation has been changed in order to preserve anonymity.
BOX 1 Framework of outcome domains following stage 2
Effectiveness
Discharge outcome/direction of care pathway.
Delayed discharge/current placement appropriateness.
Length of hospital stay.
Readmission (i.e. readmitted to the same setting within a specified period).
Clinical symptom severity/treatment needs: patient/carer rated.
Clinical symptom severity/treatment needs: clinician rated.
Treatment response/recovery measures: clinician rated.
Treatment response/recovery measures: patient/care rated.
Reoffending (formal charges/convictions).
‘Offending-like’ behaviour (no formal charges).
Incidents (violence/self-harm) in service.
Risk assessment measures.
Security need (i.e. physical/procedural/escort/leave).
Adaptive functioning.
Engagement in treatment/services.
STAGE 2: PATIENT AND CARER CONSULTATION GROUPS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
24
Effectiveness domain
Length of hospital stay/readmission/pathways
Length of stay in hospital was identified as an important outcome variable by patients, and a number were
frustrated by what they saw as extended time in treatment. However, some of the carers we consulted
did not believe a shorter length of stay was necessarily a positive outcome, with fear being expressed by
several carer participants regarding premature discharge.









Patient and carer experience
Patient experience: involvement.
Patient experience: satisfaction/complaints.
Quality of life: clinician rated.
Quality of life: patient rated.
Therapeutic climate.
Access to work/meaningful activity (when appropriate).
Carer experience: communication.
Carer experience: involvement.
Closeness to ‘home’ area.
Level of support/involvement in community (when appropriate).
BNF, British National Formulary.
Italic = new subdomain following stage 2.
BOX 1 Framework of outcome domains following stage 2 (continued)
DOI: 10.3310/hsdr05030 HEALTH SERVICES AND DELIVERY RESEARCH 2017 VOL. 5 NO. 3
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Morrissey et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
25
The fact that the service wasn’t there in the community to start with will make his hospital stay longer.
So we can’t just look at the hospital stay – it has to be the overall picture.
Carer
Longer length of stay is not worse – I don’t want him pushed out too soon before he is ready.
Carer
Just because they are out of hospital does not mean they are better.
Carer
Patients in high secure hospital naturally saw a medium secure unit as an appropriate pathway and those
in medium and low secure units were looking to community discharge as an indication of progress and
positive outcome. Moving up levels of security or readmission to hospital were perceived by patients as
negative (albeit sometimes necessary) outcomes. A number of carers noted that frequent changes in
hospital or living environment were destabilising and, therefore, constituted a negative outcome.
Placement appropriateness/meeting clinical needs
Placement appropriateness was reported to be very important to carers and patients, with delayed
discharge in a progressive direction being a particular concern (e.g. owing to appropriate unit or
accommodation availability). Indeed, placement appropriateness in terms of meeting the relative’s specific
needs was considered more important to many carers than distance from home:
I would much rather he be further away for 8/9 months [and get the right treatment] than be nearer
for 18 months.
Carer
It is very important for people to go to a place where they are happy. Not just because it is closer to family.
Patient
Carers and patients reported that it was important that specific clinical needs were met by appropriate care
and treatment in order that progress could be achieved. This included both the model of care (e.g.
whether or not it was appropriate for a patient with autism), psychological treatment (e.g. specific
treatment programmes) and appropriate levels of meaningful activity being available.
You have to be able to do your offending treatment. I need an arson group and there isn’t one starting.
Patient
[I need] Psychology . . . the Moving On group . . . they make you a pack so you know what to do.
Patient
Other hospitals let patients get real jobs. I want this to happen in this hospital.
Patient
It’s boring here there isn’t enough to do.
Patient
Carers were very clear that their priority for their relatives was an appropriate individualised pathway
through hospital care, as opposed to rigid programmes which had to be adhered to regardless of the
individual’s needs:
I know from meetings there seemed to be a lot ‘he needed to do this this and this’ – we can’t do this
before we do this’ . . . almost setting him up to fail. This is how it works whether you engage or not,
whether it’s relevant or not and therefore if it’s not relevant and they’re not going to engage it’s a fail
before they’ve started.
Carer
STAGE 2: PATIENT AND CARER CONSULTATION GROUPS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
26
It has got to be individually led.
Carer
He needed an individualised package of support which was right for him.
Carer
Finally, when it came to moving into the community from hospital, carers in particular were concerned that
an ‘appropriate’ placement constituted adequate levels of support to keep people safe:
Coming home with me or if he was left in a little flat, he wouldn’t take his medication – he’d go on
the drugs and then he would kill somebody or somebody else would kill him.
Carer




Participants were asked what changes would indicate an improvement in their own or their relatives’
health. Both patients and carers recognised that there would be indicators of clinical improvement which
would be reflective of therapeutic change and progress. These included a reduction in the frequency of
incidents of violence and self-harm, as well as perhaps less tangible clinical change.
A reduction in incidents. Reduction in restraints, using diversion more frequently,
pre-empting incidents.
Carer
[I will know there is change when] he joined in to the real world again because at the moment he is
living in . . . his world.
Carer
Clinical progress was typically described by patients as ‘communicating better’ or ‘getting angry less often’:
Before I wouldn’t engage in conversation and now I’ve learnt different strategies so I don’t kick off
so often.
Patient
A better attitude towards staff and not taking your bad day out on a staff member.
Patient
Patients also seemed to recognise the difficulty of identifying and measuring progress, often identifying
more qualitative changes:
I know what it feels like when I am better . . . I don’t put my head in my hands as much anymore.
Patient
Some people ‘toe the line’ and pretend they’re more agreeable but they aren’t really on the inside.
Patient
There was a feeling expressed by some carers that patients do not really understand what they have to
achieve to make progress and that there was too much emphasis on ‘incidents’ in determining progress:
Every time he does something [the goal] gets further ahead. And [name] goes why the hell am I doing
this; what’s the point of doing it if I am always going to get failed.
Carer
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Furthermore, some carers felt that they were often in a better position than staff to identify nuanced
changes in their relative’s functioning, and that this should be included in assessments of change.
[they should get] feedback from families . . . because the families know the person . . . we know our
family members best and if the family members flag up a concern or alternatively they say they can
see an improvement that should be as critical as the professional.
Carer
A number of patients emphasised that an increase in positive behaviour should be as reflective of change
as a decrease in negative behaviour. For example, using low-stimulation areas as opposed to being nursed
in seclusion should be seen as positive progress even if incidents were ongoing.
Finally, one carer made the important point that an increase in violent incidents per se need not necessarily
be construed as a bad outcome:
It’s important to recognise that even if someone has a bad patch that isn’t a bad outcome – the
outcome is how it’s managed. If the staff can see them through the bad patch it’s not necessarily a
bad outcome if the service manages it appropriately.
Carer
Similarly, a higher level of observation/staffing was not necessarily seen as negative, if that was necessary
for an individual:
I wouldn’t want a reduction [in staffing] because it keeps him happy and safe.
Carer
Finally, a number of participants felt that a concentration on the number of incidents was simplistic and
that there should instead be an emphasis on a more nuanced analysis of them:
There is too much focus on incidents and not on understanding them . . . taking it back to the
beginning of the process as opposed to just dealing with what the consequences are.
Carer
I get fed up with hearing about the same thing . . . you should just take it off the record and put
it somewhere.
Patient
Finally, both patients and carers also spontaneously mentioned engagement with services and therapies as
an important positive indicator of clinical progress:
I know when I am doing well. I talk to staff more . . . I’m doing my groups.
Patient
Talking to staff having a good relationship with others. I’m a peer facilitator now.
Patient
. . . at the moment he doesn’t engage in any therapies . . . if it doesn’t meet his criteria he’s not going
to bother to engage.
Carer
Reoffending on discharge
Both patients and carers mentioned staying ‘safe’ on discharge as being a positive outcome. Although they
talked little about reoffending specifically as an outcome domain which required measurement, a number
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of the carers considered themselves at potential risk as victims and their own safety was evidently
important to them:
If they did say take him home now I’d be too scared.
Carer
Reduction in risk assessment ratings was not mentioned spontaneously, perhaps because patients and
carers are less aware of these methodologies than practitioners. Nonetheless, both patients and carers
clearly understood the concept of risk reduction and saw it as important.
Adaptive functioning
Patients were very enthusiastic about hospital treatment aimed at improving their life skills such as
budgeting and work skills, but some were also fearful that hospital had caused them to lose skills they had
previously had:
Since we’ve been locked up here we don’t get a chance to do that sort of thing [budget] so you don’t
know what to do when you get it [money].
Patient
I haven’t been given skills like cooking and cleaning . . .
Patient
Other hospitals let patients get real jobs. I want this to happen in this hospital.
Patient
A carer also mentioned loss of adaptive skills as a negative outcome of hospital care:




The patients we consulted, particularly those in high security, mentioned a reduction in incidents of
seclusion as being a relevant outcome indicator. One pair of parents also mentioned reduction in staff
assaults and restraint as a pertinent outcome domain for their son.
Once again some interviewees resisted the focus on negative events and considered that positive examples
of behaviour, and seclusion avoidance in previously high-risk situations, should be monitored.
Restrictive practices: medication
Although some carers identified medication as having led to improvements, medication reduction was
seen to be a relevant goal for some patients and some parents:
A reduction in PRN and other medication [is a goal].
Carer
If he could come off olanzapine, that would be progress.
Carer
It seemed to be important to patients and carers that patients’ experiences of medication were considered,
which was an area that had not been considered in the literature. Indeed, a number of patients and carers
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expressed concerns about perceived overmedication and concurrent side effects and viewed this as a
restrictive practice:
He’s never been on this amount of medication . . . he’s so heavily dosed up . . . If he’s been medicated
to manage his behaviour he’s not learned how to manage his behaviour.
Carer
Can you be careful about medication and patients being overdosed?
Patient
Victimisation
Patients evidently had a need to feel ‘safe’ in hospital. A number of patients spontaneously mentioned
victimisation by other patients as something they had experienced in hospital and, therefore, a reduction in
such incidents was considered desirable as a service-level outcome goal.
Patient (and carer) experience domain
Quality of life
Both patients and their carers reported that in hospital and beyond discharge from hospital the quality of
life they would achieve was of vital importance to them. In summary, their hopes and priorities were much
the same as most people: a home, jobs, relationships and community involvement, but with an emphasis
on quality support.
Appropriate accommodation and level of support in the long term
The carers we consulted emphasised that discharge from hospital ‘is not the end of the story’ for them
and, therefore, monitoring of long-term outcomes post discharge is important:
[T]here’s a whole long chapter after that . . . and it has to be looked at in the context of that and not
well we’ve been discharged from hospital so somebody else – some other authority – can take them
over so we’ve got rid of them and that is that file closed.
Carer
In terms of appropriate homes post discharge from hospital, carers expressed a preference for high-quality
accommodation that meets their relative’s individual needs in terms of support. They were also clear that
inadequate support would lead to increased risk:
He would be in accommodation that was specifically designed for people with autism, but he had
sufficient support with people who actually understood his condition and were able to spot the
warning signs so I didn’t have to keep flagging them up. And that they would possibly move him into
independent living . . . [with] ongoing regular support and checking up which is the low level
preventative support [which] stops things happening; you haven’t got a measured outcome of what
you stopped because you’ve only got somebody’s idea of what could have happened.
Carer
He needs an individual planned package with sufficient staff with appropriate training. They need to
put a tender out for staff who want to work with him.
Carer
[Name] will need 24-hour support for the rest of his life.
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For carers in particular, confidence in the long-term nature and consistency of the support received by their
relative was vital:
[S]he went from being escorted everywhere to be put in a flat, see you later. That went . . . rapid
downhill in less than a year.
Carer
I hope it’s for life.
Carer
We don’t want the care to be changing, we want to know that in future years the care will be the
same . . . we need to know he’s going to be cared for the rest of his life.
Carer
I just don’t have much faith in if I wasn’t around I don’t think he’s be very well looked after.
Carer
It was also clear that for some carers back-up of an inpatient service in times of crisis was also important:
[In crisis] for him to go back in a secure unit because he’s a danger when he does deteriorate.
Carer
The patients we consulted typically mentioned wanting ‘supported living’-type arrangements, although
some also wanted to live independently, with professional help they could call on should they have
the need:
[S]omewhere with staff to help you if you need it.
Patient
I would like to see a doctor when I need to – I don’t want a long wait as things could escalate.
Patient
Meaningful activity
For patients, having paid employment was identified very strongly as an important ‘quality-of-life’ factor in
the community. Similarly, hospital patients described wanting more meaningful activity and to experience
less boredom:
Best thing was my kitchen cleaner job in my other hospital.
Patient
Having a job keeps you out of trouble.
Patient
I want to do paid work not voluntary.
Patient
A job to keep you busy . . . I had a job in Waitrose before in the shop helping people get
their shopping.
Patient
I want to work as a tree surgeon.
Patient
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I used to work outside in a charity shop. That was very good.
Patient
Carers naturally also wanted their relatives to be able to achieve goals within their abilities:
We want him achieving something we are proud of like any parent.
Carer
Relationships and community involvement
Relationships with others, including family, friends and pets, and the development of intimate relationships
were considered important, particularly by the patients themselves:
I’d like a girlfriend. I need to do more confidence work in psychology.
Patient
I want to have a pet for a companion, to look after it. When you come home from work and the dog
is at the door waiting for you.
Patient
Community involvement and the development of social networks on discharge were spontaneously
mentioned as important outcomes by both patient and carer groups. Examples given in addition to paid
work were church groups, educational programmes and using community facilities.
Carer satisfaction: communication and involvement
The carers we consulted generally had clear views on whether or not they were satisfied with the service
their relative was in, and this level of satisfaction evidently was an important outcome for them. Satisfaction
clearly led to carers experiencing less worry and concern in relation to their relatives’ well-being:
The hospital are fantastic, the staff are fantastic and at long last somebody is realising the amount of
problems he has got and that is one of the problems I had before.
Carer
It is a dream come true. The place where he is now, it’s lovely . . . it’s a dream for places like that to
be about.
Carer
They have got the service he needs right now. It’s as good as it gets for me right now.
Carer
The ultimate goal for carers was to feel secure in the knowledge that their relative would be cared
for appropriately:
Not having to be worried about him, if we died tomorrow services would be there for him and do
what was best for him without thinking of the cost.
Carer
Although some carers were happy with their involvement in the care, others felt that they had had to fight for
the right services in the past, and others felt less involved than they should have been in their relative’s
current care:
There was nothing much we could say which would be taken on board . . . it was very much ‘no,
this is what we think’.
Carer
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I was asking for help in the community for years before my son was admitted to hospital.
Carer
Communication with carers was raised as an important issue, with some carers feeling that communication
from services was excellent and others feeling that it could have been much better:
We can ring up or turn up at any time.
Carer
I am part of the team there, I go to ward rounds and I feel we all have valid points of view and bring
different strengths to the team.
Carer
The staff is supposed to phone me every 6 weeks if there’s been an update but they don’t . . . it’s the
only thing I can fault.
Carer
[T]he messages I am leaving . . . there’s no return call and then its days and days and I am sort of
banging my head against a wall. And then your relationship with the people dealing with the relative
are breaking down because there is a lack of trust, there’s a lack of communication, you are not
included in decisions or discussions so the whole thing is really not working is it basically.
Carer
Finally, a need for support for carers was identified, which was not always in place:
The situation, the hospital, impacts on families. How they are getting on impacts on how we feel outside.
Carer
I’ve never been in touch with anybody . . . if I’m ever struggling with anything or having questions I
feel are unanswered, if there’s any groups within the hospital for getting to get in touch with, I’ve not
been given any information [about them].
Carer
Conclusions
Although necessarily limited in its scope, the consultation with parents and carers validated the importance
of some of the outcome domains that have been studied in the literature and that were described in
Chapter 2. However, it was clear from the consultation that the original overarching domain of
‘patient experience’ needs to be expanded to include the experience of carers, an area that had not been
reflected in the FIDD literature. In addition, the consultation identified a number of further subdomains of
outcomes from services that had not been identified in the systematic review of research studies.
These additional subdomains (or areas within subdomains) are summarised as follows:
Effectiveness domain:
l treatment response/recovery (patient or carer ratings as opposed to clinician ratings)
l acquiring adaptive functioning skills
l evidence of engagement with therapies and services.
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Patient safety domain:
l safeguarding/victimisation of patients and patients’ experience of safety
l overuse of medication (specifically in term of patient perceived overmedication/misuse/side effects).
Patient and carer experience domain:
l carer experience (including satisfaction, involvement and communication with services)
l closeness to home area
l access to work/meaningful activity (in hospital/in community)
l level of support in the community
l involvement in the community.
These areas are incorporated into the outcome framework developed at stage 1 in Box 1.
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Chapter 4 Stage 3: Delphi survey of professionals
Aims
The aims of stage 3 of the project were to:
1. Gain consensus on expert/senior clinician views on the most important outcome domains for use in
future evaluation of FIDD services, based on the domains identified from stages 1 and 2. This included
both patient-related outcomes and aspects of the quality of care in services.
2. Identify preferred outcome measures/indicators and their important domains and those being used in
services at the time of the study.
Method
The Delphi technique is particularly useful for inquiry into opinion regarding priorities and future areas for
research.77,78 Using an iterative, multistage process, this method seeks to gain a group consensus on a
significant issue when agreement is required.
An adapted Delphi method comprising two rounds was conducted online in August 2015. The survey was
distributed via a mechanised survey tool (Bristol Online Survey). Within the three overarching outcome
domains of ‘effectiveness’, ‘patient safety’ and ‘patient experience’, a list of 31 subdomains/indicators was
created from those that had been identified at stages 1 and 2. The Delphi asked participants for their
views on the most important/highest priority outcome subdomains using quantitative rating methods.
The survey is in Appendix 6.
Participants
Members of the Clinical Research Group in FIDD services were invited to participate in the Delphi exercise.
In addition, senior clinicians and commissioners in the field (identified by the Project Steering Group) were
contacted. An intended sample size of 15–20 experts was sought in line with Delphi recommendations.79
Participants were eligible to participate if they had clinical, academic, managerial or commissioning
experience of working in FIDD services. No specific exclusion criteria were applied given the purposive
sampling method. Individuals were asked to highlight their professional background, current area of work
(i.e. clinical/academic/commissioning/managerial), type of FIDD service(s) by level of security in which they
were currently working and number of years of experience working within such services.
Procedure
Participants were contacted by e-mail to explain the study and to seek participation. For round 1,
76 individuals were invited to take part. The invitation e-mail provided the rationale and intended aims
of the Delphi exercise. The web link, closing date and a contact for further questions were also provided.
On opening the link, participants were provided with the information sheet (see Appendix 6) and
instructions for completing the survey.
If respondents consented to continue, they were asked to provide brief professional background information
as described above. Next, participants rated how important each of the 31 outcome subdomains was for the
evaluation of (FIDD) services, within the three superordinate domains of effectiveness (15 subdomains
presented), patient safety (six subdomains) and patient experience (10 subdomains). A Likert scale anchored
1 (not at all important) to 5 (extremely important) was used to rate each item, with each score having
operationalised definitions. For each subdomain participants were able to supply their preferred measures or
indicators in a free-text box. Participants were then asked to specify any additional outcome subdomains
or indicators which they considered as important from their expert knowledge. Following this, participants
were asked to select up to five subdomains which they considered to be the most important/highest priority.
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This included subdomains already identified as well as any additional items. Finally, in order to fulfil the
study’s second aim, all participants indicated the outcome measures used routinely to collect data on all
patients in their own service(s). Respondents had 2 weeks to complete the first round. A reminder e-mail
was sent 5 days before the closing date to those who had not responded.
Those who completed the first round were invited to take part in the second round (see Appendix 7).
The e-mail was sent on an individual basis with the web link, closing date and the participant’s individual
round 1 ratings in a portable document format (PDF) attachment. On continuing to the survey web page,
further instructions were provided. It was outlined that the second round was an opportunity to reappraise
ratings in the light of the average group response, which was provided adjacent to each subdomain.
First, participants were asked to rate the importance of each subdomain using the same Likert scale.
Second, participants were asked to select up to five subdomains that they perceived to be the most
important/highest priority. Participants were reminded that they did not have to change their answer from
their original response if they did not wish to do so. Round 2 was available to complete over a 2-week
period, with a reminder e-mail sent at the halfway point.
Analysis
Descriptive methods were used to report findings. Frequency data were generated to describe the
professional backgrounds of participants. Percentages and average figures were calculated to describe
the ratings made in rounds 1 and 2. The consensus level for items rated using the Likert scale was set
at an average rating of 4.0 or above (i.e. items rate as either ‘moderately’ or ‘extremely’ important).
The percentage of participants who ranked each subdomain in their top five was calculated. Free-text
answers were analysed using content analysis.
Ethical and governance considerations
The Delphi study was reviewed by the Nottinghamshire Healthcare NHS Foundation Trust Research and
Development Department. As only professionals took part, ethics approval was not deemed to be required
and consent was implied by participation. The results were downloaded in an anonymous format onto an
encrypted computer. A participant identifying number generated by the Bristol Online Survey was known
only to the research assistant. Responses were kept strictly confidential. Direct quotations from free-text
answers were anonymised so as not to be traceable back to individuals. Data were stored for the duration
of the research project only and then deleted.
Results
Characteristics of participants
A total of 17 respondents completed round 1 (22% response rate). The majority of participants were
psychologists and psychiatrists who worked in a clinical role at the time of participation (Figures 2 and 3).
Respondents had on average 12.5 years’ experience of working in FIDD services (range 1–25 years). Fifteen
of these respondents participated in the second round (88% response rate).
Although all security levels of FIDD services were represented by respondents, the majority were working in
medium and low secure care as shown in Figure 4. Seven respondents were working across either two or










FIGURE 2 Area of work.
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Ratings
In round 1 respondents were asked to rate how important they thought each outcome subdomain was for
the evaluation of FIDD services. The subdomains with an average group score from round 1 of 4.0 and
above (the consensus threshold level) were presented in round 2. Participants rerated each item. The mean
scores were then calculated for each subdomain and are presented in Table 8.
None of the items was rated as ‘not at all important’ or ‘slightly important.’ There were five items which
did not reach the consensus level at round 1 (length of stay, security needs, adaptive functioning, clinician-
rated quality of life and closeness to home area). A decision was made to retain one item (length of stay)
as, paradoxically, this item was highly ranked in the ‘top five’ domains section. At round 2, two items
(length of stay and physical health) did not reach consensus level.
The subdomains that gained the highest ratings at the end of round 2 were discharge outcome, treatment
response/engagement, reoffending (effectiveness domain), premature death (patient safety domain),
therapeutic milieu and access to meaningful activity (patient experience domain).
Top five outcomes
Participants selected up to five subdomains that they believed were the most important/highest priority for
the evaluation of FIDD services. The percentages of respondents who endorsed each subdomain as one of
their most important outcomes were calculated for both rounds and are presented in Table 9.
Suggested measures/indicators
Professionals were asked to suggest an ideal or preferred measure/indicator for each subdomain using a
free-text response.
Discussion
A total of 15 experts completed both rounds of the survey; they had an average of 12.5 years of
experience and represented a wide range of FIDD services. Although the total number of respondents was






















Locked rehabilitation 2 (7.1%)
Non-secure or community 
LD, ID or  ASD service
7 (25%)
FIGURE 4 Type of service currently working in. ASD, autism spectrum disorder; ID, intellectual disability;
LD, learning disability.
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TABLE 8 Average ratings for each subdomain
Effectiveness R1 R2 Change
Discharge outcome/direction of care pathway 4.53 4.80 +0.27
Treatment response/engagement 4.65 4.73 +0.08
Reoffending (charges/reconvictions) 4.59 4.60 +0.01
‘Offending-like’ behaviour (i.e. behaviour that did not result in charges) 4.47 4.53 +0.06
Recovery measures/progress on treatment goals (clinician rated) 4.47 4.47 0.00
Risk assessment measures 4.35 4.47 +0.12
Recovery measures/progress on treatment goals (patient rated) 4.53 4.40 –0.13
Clinical symptom severity/treatment needs (clinician rated) 4.41 4.40 –0.01
Clinical symptom severity/treatment needs (patient rated) 4.24 4.40 +0.16
Readmission (i.e. the patient is readmitted within a specified time period) 4.00 4.27 +0.27
Incidents (violence/self-harm) 4.29 4.20 –0.09
Delayed discharge/current placement appropriateness 4.24 4.07 –0.17
Length of hospital stay 3.65 3.40 –0.25
Security need (i.e. physical/procedural/escort/leave) 3.94 N/A N/A
Adaptive functioning 3.82 N/A N/A
Patient safety
Premature death and suicide 4.59 4.73 +0.14
Victimisation/safeguarding 4.53 4.47 –0.06
Restrictive practices (i.e. seclusion/segregation) 4.29 4.40 +0.11
Restrictive practices (i.e. restraint) 4.29 4.33 +0.04
Medication (i.e. PRN/exceeding BNF prescribing limits) 4.24 4.07 –0.17
Physical health 4.12 3.87 –0.25
Patient/carer experience
Access to work/meaningful activity 4.65 4.60 –0.05
Therapeutic milieu 4.41 4.60 +0.19
Support/involvement in community 4.35 4.47 +0.12
Quality of life (patient rated) 4.59 4.40 –0.19
Patient experience: involvement 4.41 4.33 –0.08
Carer experience: communication 4.18 4.20 +0.02
Patient experience: satisfaction/complaints 4.29 4.07 –0.22
Carer experience: involvement 4.06 4.07 +0.01
Quality of life (clinician rated) 3.94 N/A N/A
Closeness to ‘home’ area 3.59 N/A N/A
BNF, British National Formulary; N/A, not applicable; R1, round 1; R2, round 2.
Dark shading = average score of ≥ 4.5; light shading = average score of ≤ 4.0.
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among experts, rather than generalising to a larger population, obtaining a sufficient degree of expertise
and a representative panel can be considered more important than obtaining a large sample.
What are the most important/highest priority outcomes?
There were six subdomains which were clearly rated as greatest importance by respondents (shaded in
Table 9). Clinical symptom severity, treatment response and reoffending were most frequently endorsed
as being within the top five most important subdomains. In addition, recovery/progress on treatment goals
and risk assessment measures and discharge outcome were also most commonly ranked as being the most
important outcome domains. This broadly concurred with the Likert scale ratings. By the end of the second
TABLE 9 Frequency of participants who rated each subdomain as the top five most important (%)
Effectiveness R1 R2
Clinical symptom severity/treatment needs 70 80
Reoffending/offending-like behaviour 59 80
Treatment response/engagement/insight 47 73
Risk assessment measures 41 67
Recovery measures/progress on treatment goals 41 67
Discharge outcome/direction of care pathway 41 53
Length of hospital stay 24 13
Adaptive functioning 24 13
Delayed discharge/current placement appropriateness 18 13
Readmission 18 13
Incidents (violence/self-harm) 18 0
Security need (i.e. physical/procedural/escort/leave) 12 0
Patient safety
Restrictive practices (i.e. seclusion/segregation/restraint) 12 7
Premature death and suicide 12 0
Medication (i.e. PRN/exceeding BNF prescribing limits) 12 0
Physical health 6 0
Patient safety in general 6 0
Victimisation/safeguarding 3 0
Patient/carer experience
Access to work/meaningful activity (when/where appropriate) 24 13
Patient experience 24 0
Quality of life 12 0
Therapeutic milieu 6 0
Carer experience 0 0
Closeness to home area 0 0
Support/involvement in community (when/where appropriate) 0 0
BNF, British National Formulary; R1, round 1; R2, round 2.
Shading= domains in which consensus is achieved.
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round, respondents favoured items under the superordinate domain of effectiveness only, with only a few
respondents including items from patient safety or patient experience in their top five.
Although in round 1 there appeared to be little difference between the ratings of most domains, if the
Likert rating and the top five are combined, the second round identified clear consensus for the nine most
highly rated outcome subdomains, as shown in Box 2.
It is worth noting that in round 1, reoffending (formal reconvictions) and offender-like behaviour (activity
that could be construed as an offence but for which no formal convictions or criminal justice system
involvement followed) were similarly rated. One participant emphasised that the latter was ‘as important
as formal reconvictions’ to measure. Another respondent highlighted ‘offender-like’ behaviour was of
particular importance ‘to capture in an LD [learning disability] population’. In round 2, these two outcomes
were therefore presented as one subdomain to reflect this.
Additional subdomains
Only one participant suggested an additional subdomain, degree of patient insight, which did not appear in
the original list of items presented in round 1. This was combined with the ‘engagement’ item at round 2,
as it was considered to be similar in theme.
Current use of outcome measures
In round 1, participants were asked to indicate any outcome measures used to collect routine data on all
patients in the service(s) in which they worked. Table 10 provides a summary of responses. Services
routinely measured levels of risk using structured clinical judgement methods (most commonly with
the HCR-20). Change on risk measures (such as the HCR 20 and Short-Term Assessment of Risk and
BOX 2 Highest priority subdomains (rating and ‘top five’ method combined)
Effectiveness
Discharge outcome/direction of care pathway.
Recovery measures/progress on treatment goals.
Global treatment response/engagement/insight.
Clinical symptom severity.
Reoffending (charges/reconvictions) and offender-like behaviour.
Risk assessment.
Patient safety
Premature death and suicide.
Patient experience
Therapeutic milieu.
Access to work/meaningful activity.
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TABLE 10 Percentage of respondents who reported using each measure/indicator routinely in their service(s)
(round 1: n= 17)
Effectiveness %
Risk assessment measures including
HCR-20 47.1
Short-term Assessment of Risk and Treatability 23.5
Dynamic Risk Assessment and Management System 5.9
Short Dynamic Risk Scale 5.9
St Andrew’s Sexual Behaviour Assessment Scale 5.9





Length of stay 41.2
Delayed discharge 17.6
Discharge outcome/direction of care pathway 17.6
Recovery star (and versions) 17.6
Clinical symptom severity measures including
Clinical Outcomes Routine Evaluation – LD 17.6
Brief Psychiatric Rating Scale 5.9
EPSs 5.9
Schedules for Clinical Assessment in Neuropsychiatry 5.9
Attitudinal, motivational and skills assessments (used pre, during and post psychological interventions) 5.9
Modified Overt Aggression Scale 5.9
Number of patients in psychological treatment 5.9
Brooklands Outcome Scale Secure 5.9








Unspecified patient-experience measures 17.6
Carer Satisfaction Survey 11.8
EssenCES 11.8
Patient Satisfaction Survey 11.8
25 hours of meaningful activity 5.9
Friends and Family Test 5.9
Involvement in community and access to work/meaningful activity 5.9
Main Identified Problem Scale 5.9
My Shared Pathway 5.9
Where general subdomains are indicated, no specific measure/indicator was suggested.
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Treatability) was clearly considered important, despite the fact that the literature review indicated that
there are very few studies that examine change over time in risk measures as a result of treatment. Those
that do exist suggest that the measures are quite insensitive to change. It should also be noted that the
authors of the HCR-20 caution against ‘totalling up’ of scores, which is the only way of measuring change
in rated risk, unless only the summary risk rating (high, medium, low) is used. Totalling of scores is also
complicated by the new ‘relevance’ ratings in the HCR-20 latest Version 3, which is now in use. The rated
importance of risk measures as an outcome variable by professionals fails to acknowledge such problems
and may be driven more by their availability owing to mandated use as part of Commissioning for Quality
and Innovation targets.
There was not a clearly preferred measure of clinical change or treatment progress. Clinical symptoms
were most commonly rated using HoNOS-secure or other versions of HoNOS. Patients’ views on their
own progress were not routinely collected, despite their rated importance, although a small number of
participants mentioned trust-led patient satisfaction surveys or patient self-risk ratings.
Incident data and associated restrictive practices were routinely monitored, but there was no evidence of
a standardised coding system across services, which would be necessary for benchmarking purposes.
This may reflect the multiplicity of service providers in this sector.
Additional issues raised
Respondents were given the opportunity to provide additional free-text responses in both rounds. The key
themes are as follows:
l Barriers to measuring outcomes: participants reflected on the difficulties of measuring outcomes in
FIDD services in general. One participant summarised the issue as ‘a lack of clear objective measures
and outcomes for forensic intellectual disabilities services’ suggesting an absence of current guidance
and paucity of appropriate outcome measures for the population. Another respondent indicated that
‘there is a huge reliance on clinical judgement and this can be flawed and biased’. As the literature
review found, it is notable that the majority of collected data reflect professional opinion and there is
a relative dearth of outcomes from the patient perspective.
l Additional subdomains: participants were given the opportunity to suggest any subdomains which
were not presented in round 1. The limited number of extra subdomains suggested that the original list
of subdomains was comprehensive. It therefore appeared that the relevant and important items were
captured by the framework developed from stages 1 and 2.
l Discord around direction of ‘positive’ outcomes: with regard to length of stay, the comments of some
participants highlighted ambivalence as to the desired direction of this outcome indicator. For example,
although having a shorter length of stay may initially appear to be a positive outcome, it was noted
that it is ‘important to pick up inappropriate early discharges due to bed pressures’ among inpatient
services.
It was also noted that, for some forensic patients, an extended length of stay may be clinically
appropriate and, therefore, not a ‘negative’ outcome, a theme echoed in the carer interviews.
This ambivalence about length of stay as an outcome indicator may be reflected in its relatively low
importance rating (indeed, it fell below the consensus threshold in both rounds).
l Ambivalence regarding closeness to home area: although it is emphasised as being desirable in a range
of policy papers, interestingly, closeness to home area was not considered a priority by professionals.
One respondent commented that ‘our regional and supra regional Gatekeeper role sometimes
experiences the benefit of some “geographical distance”’. This implies that for some patients living
near to their family or local authority area may not necessarily be a constructive outcome.
l Patient-rated outcomes: several respondents recommended using patients’ self-reported data to
capture outcomes including patients’ assessment of how safe they perceive they are – often relates
to ability to engage in therapeutic change and achieve treatment goals/reduce risk. Professionals also
outlined ways that this could be achieved, for example ‘co-production of such [patient satisfaction]
measures from within our patient advisors’. It is notable that ‘My Shared Pathway’80 was intended by
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the Department of Health to be an outcomes monitoring system; it was mandated for use as a
CQUINN (Commissioning for Quality and Innovation) target for secure services in 2013 and includes
patient ratings of progress on treatment goals. The almost total lack of mention of this tool by
clinicians (one respondent) suggests that it is not being used consistently as an outcome measure or
indicator by IDD services.
Finally, it is noteworthy that all subdomains were generally rated towards the upper end of the scale,
indicating that respondents believed that all items had a degree of importance. Nevertheless, clear
consensus around key priorities emerged.
Conclusions
The aim of the Delphi exercise was to obtain an expert group consensus on the most important/highest
priority outcomes to be measured in the evaluation of FIDD services in the future. We were therefore
interested in service-level outcomes, as opposed to outcomes that clinicians might assess at individual
patient level in the consideration of progress and discharge, although these may overlap. A total of
15 experts completed both rounds of the survey. The participants had an average of 12.5 years of
experience and represented a wide range of FIDD services.
In summary, the majority of the most highly rated items came under the superordinate domain relating to
effectiveness, with items from patient safety and patient experience domains rated less frequently as a
priority. Indeed, consensus was clearer as defined by the top five rating: the domains rated in the ‘top five’
were all in the effectiveness domain with none in the other two domains. Perhaps unsurprisingly, clinician
respondents therefore particularly prioritised items that relate to how successful services are in helping
patients to reduce their clinical symptoms and progress their treatment goals while they are receiving care, as
opposed to items reflecting service quality. These clinical effectiveness outcome domains were found not to
be well represented in the literature in stage 1, but were found to be important to the patients and carers,
particularly in terms of their own rating, in stage 2. It appears that a variety of measures and indicators could
be used to index these outcomes meaningfully (including those developed in the Department of Health-led
‘My Shared Pathway’80), but it seems there are no consistently used outcome measures across the services
represented in the survey. It may be concluded that further work needs to be conducted to develop clinical
symptom and treatment progress indicators which are both acceptable to clinicians and patients with
intellectual disabilities and are valid and reliable.
The majority of the measures that professionals reported were collected routinely in their services were
risk assessment measures (such as the HCR-20), and data on incidents and restrictive practices such as
seclusion and restraint, which are required by the Department of Health. Length of stay was also routinely
collected. Many services collected data on the same outcome subdomain, although the exact measure/
indicator will differ (e.g. one way that incidents are coded in each setting differs widely).
The findings suggest that implementing a minimum data set among FIDD services is feasible, at least for
some core measures. However, it was apparent that services, while they may collect some similar
information, do not necessarily record it systematically on databases and are even less likely to analyse
group data on a longitudinal basis, in order to identify change over time in their patients. This was also
evident from the paucity of longitudinal studies in the systematic review. This finding may well be because
services do not generally have resources to collect and analyse data systematically unless they have
research departments (which only applies to some of the larger service providers). It would therefore
require a specific research study or direction to services from commissioners to address the issue of
developing a core common data set.
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Chapter 5 Synthesis of findings and conclusions
for future research
Overview
This development project comprised three stages: a systematic review of outcome domains, measures and
indicators used in the literature; a series of consultation groups with patients and carers; and a Delphi
survey of clinicians and experts. Although they are studies with findings of independent interest, together
these allow some conclusions to be drawn about the most important domains and associated measures/
indicators for examination in outcome evaluation and research in the forensic intellectual disability field.
A key finding is that there appears to be a paucity of widely used, reliable and valid measures and
indicators in some of the important domains.
As intended, the project also allowed a group of researchers and an expert by experience in the field to
reflect together, through two day-long meetings, on what the future research needs are in relation to
outcomes from intellectual disability services.
Final framework of outcome domains
The first output is the final outcome framework which synthesises the evolving framework of outcome
domains developed alongside the three studies. For the purposes of this final framework, no domain
which had been added at any of the three stages was removed, although a small number were collapsed.
For example, ‘closeness to home area’ was subsumed under ‘patient satisfaction’, and ‘treatment response/
engagement/insight’ was subsumed under ‘recovery/engagement/progress on treatment goals’, as these
were similarly rated by clinicians and were considered to overlap. Table 11 describes this framework and
the source of the inclusion of the subdomain. It should be noted that only new domains generated from
stage 2 were added to those generated at stage 1 (systematic review). In the event, no new subdomains
were added from stage 3.
These domains are therefore those that we recommend be considered for the purposes of developing
benchmarking measurement of outcomes from all FIDD services, and for comprehensive outcome research
into such services.
Long list of indicators
The second output is a ‘long list’ of domains alongside suggested measures or indicators of the domains
identified in the framework. The stage 1 systematic review identified a range of indicators and measures
(see Tables 1–6), which have been used to index the outcome subdomains in the FIDD literature. Similarly,
the stage 3 Delphi study gave a consensus on the domains of most importance, and also allowed
identification of those measures preferred by clinicians and those that are collected routinely in services.
Stage 2 naturally did not include consideration of specific measures, as patients and carers would not
necessarily be familiar with these.
Accordingly, information gained from the study as a whole was synthesised to produce a provisional
outcome measure or set of indicators for each subdomain. This ‘long list’ was based on a combination
of robustness of research findings, clinician preference according to the Delphi exercise and ease of
collection and accessibility in services.
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The long list is presented in Appendix 8 and will serve as a draft set of important variables for a future
minimum data set and longitudinal research study (see below). Importantly, it identifies both the measures
to be collected during hospital care and those to be collected post discharge on follow-up in the community.
Those areas identified as less important by clinicians but flagged by patients and carers as important have
currently been left in the long list. In some areas we recognise that consistency with the relevant NHS
Outcomes Framework indicators and Adult Social Care Outcomes Framework should be achieved.
TABLE 11 Final framework of outcome domains
Effectiveness Source
Discharge outcome/direction of care pathway 1
Delayed discharge/current placement appropriateness 1
Readmission (i.e. readmitted to hospital or prison) 1
Length of hospital stay 1
Adaptive functioning 2
Clinical symptom severity/treatment needs (patient rated) 1
Clinical symptom severity/treatment needs (clinician rated) 1
Recovery/engagement/progress on treatment goals (clinician rated) 1
Recovery/engagement/progress on treatment goals (patient/carer rated) 2
Reoffending (i.e. charges/convictions) on discharge 1
Offending-like behaviour (no CJS involvement) on discharge 1
Incidents (violence/self-harm) (in care setting) 1
Risk assessment measures 1




Medication (i.e. PRN usage/exceeding BNF limits/side effects patient rating) 1/2
Restrictive practices (restraint) 1
Restrictive practices (seclusion/segregation) 1
Victimisation/safeguarding 2
Patient/carer experience
Patient experience: involvement in care 2
Patient experience: satisfaction/complaints 1
Quality of life (patient rated) 1
Therapeutic climate 1
Access to work/meaningful activity (when appropriate) 2
Level of support/involvement in community/social network (post discharge) 2
Carer experience: communication with services/involvement in care 2
BNF, British National Formulary; CJS, Criminal Justice System.
Source of domain: stage 1 = systematic review; stage 2= patient/carer involvement.
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Clearly, further work needs to be undertaken on the precise source of the outcome data in many
subdomains and on the exact measurement to be employed. Given the evidence of lack of comparable
outcome measures across FIDD services currently, this is a priority task which is all the more important
given the current policy context.
Current policy context
During the course of this project NHS England published Building the Right Support,80 along with a National
Service Model for people with intellectual and developmental disabilities.81 These publications are in further
response to the abuse that occurred at Winterbourne View3 and focus on transforming services in order to
increase community-based services and reduce the use of inpatient beds for people with developmental
disabilities, including those with forensic needs. The National Service Model is based around nine clear
principles with the person and their family at the centre. Specialist mental health care services, including
forensic services, should be offered within community-based settings in order to circumvent admission.
However, principle 9 recognises that hospital admission may be required for some individuals, but that
change and improvement within services is needed. For example, all hospital-based services need to be
integrated into community-based teams, while admissions need to be more clearly justified and associated
with active, clear and robust discharge planning to prevent unnecessary hospital stays. Admissions also have
to be within the context of a clear care-pathway and subject to a pre-admission Care and Treatment Review.
The findings from our current project outline some of the key indicators that are likely to index treatment
outcome as a result of stay in a secure hospital. These effectiveness indicators could be used to routinely
measure outcome during and following a hospital stay, and have implications for refining the care
pathway for individual service users. In the patient experience domain we also have identified some
important indicators for monitoring long-term outcomes for community care for these patients post
discharge, which are strikingly consistent with several of the nine principles in the new National Service
Model. Accurate collection of such data could support implementation of the model and the vision
outlined within Building the Right Support,80 as this framework will allow service providers, NHS England,
Clinical Commissioning Groups and those undertaking care and treatment reviews to objectively measure
change and progress (or otherwise) in people with IDD who have been in forensic care.
Recommendations for future research
Moving forward from the current preliminary study, our final objective was to inform and underpin a
large-scale longitudinal research project on outcomes from FIDD services. We are therefore in the process
of developing an outline protocol for further research. As an output of the preliminary studies we have
produced a list of key outcome domains (along with preliminary suggestions for measures/indicators with
which to index these domains) and we propose to investigate their reliability and validity across a further
series of studies. Our overarching goal is to create a standardised index of outcome for application across
all IDD secure hospitals in England and to develop a national minimum data set of patients with IDD
within secure hospitals which tracks them through their hospital treatment and discharge. Although key
effectiveness variables would be the focus, this data set would ideally also include the patient safety and
patient experience domain variables which cover some of the overarching principles in the new service
framework. This information could potentially be used by NHS England both to monitor patient outcomes
objectively and to provide benchmarking across services. It would also enable prediction of those patients
who make most progress and the reasons for this, including effective treatments. It should also help to
support appropriate care pathways within secure hospitals, and could highlight difficulties that need to be
addressed, such as any lack of appropriate treatment provision, which could in turn lead to a reduction in
length of stay.
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It is proposed that the first workstream would involve an initial refinement of the domains, and the specific
indicators of the domains and how they are to be measured. Our current long list, while comprehensive,
may have disadvantages with respect to the time and cost of large-scale regular data collection on all
variables, some of which may not prove valid or reliable indicators of change. We have already obtained
consensus on a smaller subset of priority areas for clinicians, but would propose to undertake a further
1-day face-to-face consensus rating exercise with experts and other stakeholders (e.g. NHS England,
patients and carers) with an aim of finalising a shortlist of core outcome measures/indicators for piloting.
Our second workstream would involve piloting our key indicators in several regions within England.
We expect that this would be done collaboratively with NHS England and other key stakeholders
(e.g. the Care Quality Commission and the Health and Social Care Information Centre). This workstream
would allow us to investigate the feasibility of data collection by services and to establish the reliability and
validity of our indictors over time. A secondary aim of this workstream would be to reduce the number of
indictors further using item response theory methodology.
Within our third workstream, having refined our effectiveness indicators, and developed a reliable,
valid and robust set, we would envisage continuing to work collaboratively with NHS England and other
partners to create a longitudinal data set of all patients with IDD in secure hospitals. We would collect and
refine these data, using a variety of methods, over a minimum period of 5 years. In summary, we therefore
envisage the creation of a national FIDD minimum data set, which follows patients longitudinally through
secure care to discharge and subsequent long-term follow-up. Patient safety and patient experience
would also be monitored at a service level. Although a number of data sources exist (e.g. NHS England’s
Transforming Care tracker; NHS Outcomes Framework; Mental Health Minimum Dataset) these do not
easily allow identification of FIDD patients, measure treatment outcome (particularly in terms of patients’
progress over time), or adequately track care pathways from secure hospital into the community or to
other outcome destinations such as prison. These areas of measurement are necessary if the Department
of Health is to achieve its vision as outlined within Building the Right Support 80 for forensic patients. It is
believed that a robust future research programme will help to support genuine and lasting change within
secure IDD services consistent with that vision. The programme should be associated with an improvement
in the key indicators for all people with IDD and forensic needs by helping to ensure that they are not
admitted to hospital unnecessarily, and, for those who are admitted, that they remain in hospital for no
longer than is absolutely necessary.
To summarise, the research priorities are therefore:
1. refining the priority domains and the measures and indicators with which to represent the domains
2. creating a longitudinal minimum data set on all patients in secure services, including follow-up at
discharge for a predetermined period.
Limitations
The preliminary research reported in this report was intended only to inform development of future
substantive research and there are therefore some limitations. The systematic review was intentionally
broadly focused and comprehensive for its primary purpose of identifying how outcomes have been
studied in FIDD services, but a synthesis of the findings of the 60 included studies themselves was beyond
the scope of the study. Such a synthesis may nevertheless have been of interest, in which case the addition
of quality ratings may have identified the studies on which to put most weight, but the reasons for not
conducting quality ratings have been clearly outlined. The Delphi survey tapped into the views of only a
small pool of 15 experts, and a more comprehensive survey with a larger sample from a more diverse
range of professional groups, including more nurses, might have identified more detail and accuracy about
data available from services. Furthermore, although carers were represented from three settings, a more
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structured and representative survey of carer ‘experts by experience’ may have added to the overall picture,
but would have been more methodologically complex and time-consuming.
The consultation with patients was limited in a number of ways, particularly in relation to the
generalisability of the views of the small number of patients consulted. First, the patients we consulted
were detained in two secure settings; we recognise that it was difficult for people with intellectual
disabilities in such settings to reflect on a subject (i.e. discharge) of which they have limited choices
or control. Furthermore, those willing and able to be consulted were by definition those most able and
engaged in services; the voices of those who were the least able or in seclusion or segregation were
not heard. In addition, those who had been discharged from services were not consulted in the study,
although those former service patients would have had an important perspective on outcomes.
Final remarks
This project comprised preliminary scoping work. While FIDD services serve a unique group of patients,
we recognise that the framework we have produced may need to be considered in the context of other
frameworks, including the recently proposed Intellectual Disability Outcomes Framework for improving the
quality of community services for people with intellectual disability was published while the current work was
ongoing.82 The five domains outlined in that framework (which directly reflect those in the NHS Outcomes
Framework83) are nevertheless covered by our three overarching domains of effectiveness, patient safety and
patient experience, but it will be important that specific indicators used are common across frameworks
when this is meaningful. Finally, we recognise that this preliminary research has not yet identified a
‘definitive’ list of outcome measures/indicators for use in services or future research; this is in large part a
result of our finding of a lack of consensus for the use of, or even existence of, measures in some of the
domains and reinforces the need for more refinement of measures as a first phase of any future project.
Dissemination strategy
The findings of this report will primarily feed into the design of future substantive research. Findings will be
accessible to professional groups and policy-makers through published papers in peer-reviewed journals,
and presentation at professional conferences. Patients and carer groups received feedback in the form of
the summary in Appendix 9.
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Appendix 1 Search strategy
PsycINFO
Date range searched: 1806 to May week 4 2015.
Date searched: 1 June 2015.
Search strategy
1. exp intellectual development disorder/ (39,999)
2. Learning disorders/ (2170)
3. Developmental Disabilities/ (10,651)
4. ((intellectual$ or learning$ or development$) adj3 (impair$ or disab$ or disorder$ or difficult$ or
subnormal$ or sub-normal$)).tw. (66,491)
5. ((mental$ or development$) adj3 (retard$ or disab$ or defici$ or handicap$ or impairment$ or
subnormal$ or sub-normal$)).tw. (58,870)
6. (feeble-minded$ or moron$ or imbecil$ or cretin$).tw. (2851)
7. de lange$.tw. (112)
8. Cri-du-chat.tw. (87)
9. (Wagr adj3 syndrome).tw. (2)
10. (down$ adj3 syndrome$).tw. (6387)
11. (Rubinstein adj3 Taybi).tw. (39)
12. (prader adj3 willi).tw. (637)
13. (williams adj3 syndrome).tw. (1038)
14. fragile X.tw. (1897)
15. ((Martin Bell or FRAXE or FRAXA) adj3 syndrome$).tw. (19)
16. (les?h adj3 nyhan$).tw. (184)
17. Adrenoleukodystrophy.tw. (151)
18. (Coffin adj Lowry).tw. (32)
19. Menkes.tw. (60)
20. Glycogen Storage Disease.tw. (43)
21. Mucopolysaccharidosis.tw. (90)
22. Rett$.tw. (1073)
23. Pyruvate Dehydrogenase.tw. (80)
24. or/1-23 (118,478)
25. forensic.tw. (14,524)




30. 24 and 29 (2011)
MEDLINE(R) (via Ovid)
Date range searched: 1946 to May week 4 2015.
Date searched: 1 June 2015.
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Search strategy
1. exp Intellectual Disability/ (82,875)
2. Mentally Disabled Persons/ (2227)
3. Learning disorders/ (12,856)
4. Developmental Disabilities/ (15,682)
5. ((intellectual$ or learning$ or development$) adj3 (impair$ or disab$ or disorder$ or difficult$ or
subnormal$ or sub-normal$)).tw. (48,293)
6. ((mental$ or development$) adj3 (retard$ or disab$ or defici$ or handicap$ or impairment$ or
subnormal$ or sub-normal$)).tw. (51,852)
7. (feeble-minded$ or moron$ or imbecil$ or cretin$).tw. (1645)
8. de lange$.tw. (793)
9. Cri-du-chat.tw. (368)
10. (Wagr adj3 syndrome).tw. (133)
11. (down$ adj3 syndrome$).tw. (17,498)
12. (Rubinstein adj3 Taybi).tw. (519)
13. (prader adj3 willi).tw. (2673)
14. (williams adj3 syndrome).tw. (1673)
15. fragile X.tw. (4927)
16. ((Martin Bell or FRAXE or FRAXA) adj3 syndrome$).tw. (202)
17. (les?h adj3 nyhan$).tw. (969)
18. Adrenoleukodystrophy.tw. (1653)
19. (Coffin adj Lowry).tw. (187)
20. Menkes.tw. (1086)
21. Glycogen Storage Disease.tw. (2005)
22. Mucopolysaccharidosis.tw. (2613)
23. Rett$.tw. (3054)
24. Pyruvate Dehydrogenase.tw. (5100)
25. or/1-24 (17,7158)
26. forensic.tw. (25,673)




31. 25 and 30 (718)
EMBASE
Date range searched: 1974 to 2015 week 22.
Date searched: 1 June 2015.
Search strategy
1. exp mental deficiency/ (124,913)
2. intellectual impairment/ (12,230)
3. developmental disorder/ (27,419)
4. Learning disorders/ (21,725)
5. Developmental Disabilities/ (24,896)
6. ((intellectual$ or learning$ or development$) adj3 (impair$ or disab$ or disorder$ or difficult$ or
subnormal$ or sub-normal$)).tw. (69,880)
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7. ((mental$ or development$) adj3 (retard$ or disab$ or defici$ or handicap$ or impairment$ or
subnormal$ or sub-normal$)).tw. (69,505)
8. (feeble-minded$ or moron$ or imbecil$ or cretin$).tw. (2271)
9. de lange$.tw. (1017)
10. Cri-du-chat.tw. (483)
11. (Wagr adj3 syndrome).tw. (157)
12. (down$ adj3 syndrome$).tw. (22,586)
13. (Rubinstein adj3 Taybi).tw. (652)
14. (prader adj3 willi).tw. (3535)
15. (williams adj3 syndrome).tw. (2497)
16. fragile X.tw. (6134)
17. ((Martin Bell or FRAXE or FRAXA) adj3 syndrome$).tw. (226)
18. (les?h adj3 nyhan$).tw. (1152)
19. Adrenoleukodystrophy.tw. (2064)
20. (Coffin adj Lowry).tw. (219)
21. Menkes.tw. (1331)
22. Glycogen Storage Disease.tw. (2559)
23. Mucopolysaccharidosis.tw. (3866)
24. Rett$.tw. (4102)
25. Pyruvate Dehydrogenase.tw. (6090)
26. or/1-25 (257,407)
27. forensic.tw. (40,822)
28. (secure adj (unit$ or hospital$ or service$)).tw. (577)
29. exp offender/ (8941)
30. offen$.tw. (23,256)
31. or/27-30 (65,604)
32. 26 and 31 (1413)
Allied and Complementary Medicine
Date range searched: 1985 to May 2015.
Date searched: 1 June 2015.
Search strategy
1. exp learning disability/ (3019)
2. exp mental retardation/ (2432)
3. exp Developmental disabilities/ (849)
4. ((intellectual$ or learning$ or development$) adj3 (impair$ or disab$ or disorder$ or difficult$ or
subnormal$ or sub-normal$)).tw. (7938)
5. ((mental$ or development$) adj3 (retard$ or disab$ or defici$ or handicap$ or impairment$ or
subnormal$ or sub-normal$)).tw. (4951)
6. (feeble-minded$ or moron$ or imbecil$ or cretin$).tw. (9)
7. de lange$.tw. (15)
8. Cri-du-chat.tw. (8)
9. (Wagr adj3 syndrome).tw. (0)
10. (down$ adj3 syndrome$).tw. (825)
11. (Rubinstein adj3 Taybi).tw. (5)
12. (prader adj3 willi).tw. (78)
13. (williams adj3 syndrome).tw. (74)
14. fragile X.tw. (81)
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15. ((Martin Bell or FRAXE or FRAXA) adj3 syndrome$).tw. (1)
16. (les?h adj3 nyhan$).tw. (4)
17. Adrenoleukodystrophy.tw. (4)
18. (Coffin adj Lowry).tw. (0)
19. Menkes.tw. (0)
20. Glycogen Storage Disease.tw. (8)
21. Mucopolysaccharidosis.tw. (4)
22. Rett$.tw. (71)
23. Pyruvate Dehydrogenase.tw. (7)
24. or/1-23 (11,351)
25. forensic.tw. (226)
26. (secure adj (unit$ or hospital$ or service$)).tw. (22)
27. exp crime/ (312)
28. offen$.tw. (339)
29. or/25-28 (698)
30. 24 and 29 (193)
Health Management Information Consortium
Date range searched: 1979 to March 2015.
Date searched: 1 June 2015.
Search strategy
1. exp learning disabilities/ (6239)
2. ((intellectual$ or learning$ or development$) adj3 (impair$ or disab$ or disorder$ or difficult$ or
subnormal$ or sub-normal$)).tw. (4440)
3. ((mental$ or development$) adj3 (retard$ or disab$ or defici$ or handicap$ or impairment$ or
subnormal$ or sub-normal$)).tw. (3030)
4. (feeble-minded$ or moron$ or imbecil$ or cretin$).tw. (7)
5. de lange$.tw. (0)
6. Cri-du-chat.tw. (0)
7. (Wagr adj3 syndrome).tw. (0)
8. (down$ adj3 syndrome$).tw. (254)
9. (Rubinstein adj3 Taybi).tw. (0)
10. (prader adj3 willi).tw. (3)
11. (williams adj3 syndrome).tw. (0)
12. fragile X.tw. (12)
13. ((Martin Bell or FRAXE or FRAXA) adj3 syndrome$).tw. (0)
14. (les?h adj3 nyhan$).tw. (0)
15. Adrenoleukodystrophy.tw. (0)
16. (Coffin adj Lowry).tw. (2)
17. Menkes.tw. (0)
18. Glycogen Storage Disease.tw. (0)
19. Mucopolysaccharidosis.tw. (3)
20. Rett$.tw. (6)




NIHR Journals Library www.journalslibrary.nihr.ac.uk
62
24. exp secure mental health services/ (195)
25. exp psychiatric secure units/ (133)




30. 22 and 29 (189)
British Nursing Index Healthcare Databases Advanced
Search platform
Date range searched: 1994 to May 2015.
Date searched: 1 June 2015.
Search strategy
1. BNI; (exp AND MENTAL AND RETARDATION).ti,ab (0)
2. BNI; ((mental* OR development*) adj3 (retard* OR disab* OR defici* OR handicap* OR impairment*
OR subnormal* OR sub-normal*)).af (1904)
3. BNI; ((intellectual* OR learning* OR development*) adj3 (impair* OR disab* OR disorder* OR difficult*
OR subnormal* OR sub-normal*)).af (7333)
4. BNI; (feeble-minded* OR moron* OR imbecil* OR cretin*).af (8)
5. BNI; Cri-du-chat.af (5)
6. BNI; (Wagr adj3 syndrome).af (0)
7. BNI; (down* adj3 syndrome*).af (453)
8. BNI; (Rubinstein adj3 Taybi).af (1)
9. BNI; (prader adj3 willi).af (27)
10. BNI; (williams adj3 syndrome).af (16)
11. BNI; “fragile X”.af (49)
12. BNI; ((Martin Bell OR FRAXE OR FRAXA)).af (2)
13. BNI; ((les?h adj3 nyhan*)).af (1)
14. BNI; Adrenoleukodystrophy.af (0)
15. BNI; (Coffin ADJ Lowry).af (0)
16. BNI; Menkes.af (3)
17. BNI; “Glycogen Storage Disease”.af (3)
18. BNI; Mucopolysaccharidosis.af (2)
19. BNI; Rett*.af (26)
20. BNI; “Pyruvate Dehydrogenase”.af (0)
21. BNI; “de lange*”.af (20)
22. BNI; 1 OR 2 OR 3 OR 4 OR 5 OR 6 OR 7 OR 8 OR 9 OR 10 OR 11 OR 12 OR 13 OR 14 OR 15 OR 16
OR 17 OR 18 OR 19 OR 20 OR 21 (7790)
23. BNI; forensic.af (904) results.
24. BNI; exp SECURE PSYCHIATRIC HOSPITALS/ OR exp MENTALLY DISORDERED OFFENDERS/ (770)
25. BNI; (secure ADJ (unit* OR hospital* OR service*)).af (527)
26. BNI; offen*.af (1270)
27. BNI; 27 OR 28 OR 29 OR 30 (2057)
28. BNI; 26 AND 31 (364)
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Cumulative Index to Nursing and Allied Health Literature
(via EBSCOhost)
Date range searched: 1806 to May week 4 2015.
Date searched: 1 June 2015.
Search strategy
1. S1. (MH “Intellectual Disability+”) (14,423)
2. S2. (MH “Mentally Disabled Persons”) (2211)
3. S3. (MH “Developmental Disabilities”) (4374)
4. S4. TX ((mental* OR development*) N3 (retard* OR disab* OR defici* OR handicap* OR
impairment* OR subnormal* OR sub-normal*)) (40,779)
5. S5. TX ((intellectual* OR learning* OR development*) N3 (impair* OR disab* OR disorder* OR
difficult* OR subnormal* OR sub-normal*)) (61,814)
6. S6. TX (feeble-minded* OR moron* OR imbecil* OR cretin*) (1735)
7. S7. TX Cri-du-chat (159)
8. S8. TX (Wagr N3 syndrome) (23)
9. S9. TX (down* N3 syndrome*) (8682)
10. S10. TX (Rubinstein N3 Taybi) (58)
11. S11. TX (prader N3 willi) (806)
12. S12. TX (williams N3 syndrome) (796)
13. S13. TX “fragile X” (1781)
14. S14. TX ((Martin Bell OR FRAXE OR FRAXA) N3 syndrome*) (25)
15. S15. TX (les?h N3 nyhan*) (150)
16. S16. TX Adrenoleukodystrophy (161)
17. S17. TX (Coffin N1 Lowry) (25)
18. S18. TX Menkes (277)
19. S19. TX “Glycogen Storage Disease” (220)
20. S20. TX Mucopolysaccharidosis (186)
21. S21. TX Rett* (3568)
22. S22. TX “Pyruvate Dehydrogenase” (196)
23. S23. TX “de lange*” (805)
24. S24. S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR
S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 (83,897)
25. S25. TI forensic or AB forensic (2740)
26. S26. TX (secure N1 (unit* OR hospital* OR service*)) (1797)
27. S27. (MH “Mentally Ill Offenders”) (1376)
28. S28. TI offen* or AB offen* (3951)
29. S29. S25 OR S26 OR S27 OR S28 (8721)
30. S30. S24 AND S29 (1195)
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Appendix 2 Inclusion and exclusion criteria
Type of study
l Any study design
AND
l Presents quantitative data post 1980
AND is one of the following:
l in press, in preparation or published in a book or scientific, peer-reviewed journal
l unpublished service evaluation report
l grey literature.
Exclude: qualitative data only.
Type of service/participant
All of the following apply:
Study includes data relating to:
l service includes forensic mental health service(s)
l IDD- or LD-specific service(s)
l adult services (≥ 18 years).
If service is mixed the IDD data are identifiable as a separate group.
Exclude: child or adolescent services.
One or more of the following apply:
l high, medium or low secure service
l locked rehabilitation service
l community forensic service.
Non-UK equivalent of any of the above.
Exclude: prison studies; probation.
Intervention
l Study evaluates/considers outcomes arising from the service as a whole.
l Study presents data on measures of effectiveness, quality or patient experience.
Exclude: studies that evaluate a specific/singular intervention (e.g. anger management).
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Appendix 3 Screening tool and data
extraction form
Screening tool
Reviewer   1             2             3                                    Study ID: 
Title: 
Year:                                                  Language or Place of study:                  
Authors: 
 
1. Type of Study  
• Any study design 
AND 
• Presents quantitative data 
AND is one of the following:- 
• In-press, in-preparation or published in a book or 
scientific, peer reviewed journal  
• Unpublished service evaluation report  
• Grey literature  
 Yes         
 No: Exclude*      
 Unsure 
Comments: 
2. Sample and Setting 
All of the following apply:- 
• Forensic/Offender service(s) 
• IDD or LD specific service(s) 
• Adult service(s) (18 years+) 
 Yes         
 No: Exclude*      
 Unsure 
Comments: 
One or more of the following apply:- 
• High, Medium or Low secure service 
• Locked Rehabilitation service 
• Community forensic service 
• Non-UK equivalent of any of the above 
 Yes         




• Study evaluates/considers outcomes arising from 
the service as a whole 
AND 
• Does not evaluate a specific/singular intervention 






 Yes         




Study measures patient-related outcomes  
OR   
Study presents potential indicators of effectiveness 
 Yes     
 No: Exclude*      
 Unsure 
Comments: 
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Decision: Is it appropriate for inclusion? 
 Yes, Include) 
 
 *No: Exclusion Reason: 
 
 Unsure. Discussed on ____/____/2015 
 
Outcome:                                                                       
              Yes, Include 
 
              *No: Exclusion Reason: 
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% Male:  
Mean Age:  
Additional Info: 
 Category 1: High secure 
 Category 1: Medium secure 
 Category 1: Low secure 
 Category 4 (Rehabilitation) 
 Community Forensic Service 
 Non-UK equivalent 
 
 Single Site                Multi-Site 
Study Design 
Details: 
 Type A 
• Cohort with follow up of any length 
• Measures data at two time points (e.g. shows 
potential change over time) 
 Type B 
• Cross-sectional study design 
• Measures data at one time point 
Method 







 Patient related clinical effectiveness 
 Patient related safety or risk measures 
 Patient/carer experience 
 Other 
 During service intervention 
 Discharge 
 Follow-up:  
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Outcome Measures/Tools 
Specific outcome measure/tool used:     Yes    No 
•  
Relevant Findings 
•     
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Appendix 4 Patient and carer information for
consultation groups
Information for taking part in Discussion Group 
 
• Next year we will be doing research to find out what happens to people 
after their stay in secure care. Before we do this we want to find out 
what patients‛ views are 
• We are inviting you to take part in a discussion group about what is 
important to you in your treatment here and in your life after secure 
hospital4 
• This will help us plan our research 
• The lead for the study is Dr Catrin Morrissey. It is paid for by the NHS 
 
Sometimes we need to see how well services are doing at helping people 
to get better – this is called an ‘outcome‛. We will be doing some research 
on outcomes from secure care.  Before we do that research we want to 
know what kinds of outcomes are important to you. 
 
We would like to hear your opinions about the ways you think you and other 
people change after treatment. We also want to know about things you 
think are important for your future.  
 
 
What you say will be confidential. The things you say will not go in your 
notes but we may write down some of your ideas, because your opinions 
are important to us.  We will not write down your name, so no one else 
will know    who has said what. The things that you tell us today will not 
affect your care or treatment.  
 
We are doing this discussion group so that we can include the things that 
are important to you, when we do our study in the future. 
 
Are you happy to take part in the discussion? You can change your mind  
 
  Yes, I am happy to take part 
 
 
   




Name:                                           Date:_______________        
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We are writing to you to as a carer of a patient at St. John’s Hospital, Partnerships in Care. 
We would like to invite you to take part in a discussion group.  
 
• We are doing research to find out what happens to people during and 
after their stay in secure care. 
• We want to find out what carers/relatives views are 
• The discussion group is about what you think is important in the 
treatment of the person you care for both here and in future places. 
• A payment of £120 will be given for your time 
• Plus, travel expenses will be provided (at 45p per mile) 
 
Please take time to read the Information Sheet enclosed with this letter carefully. This 
provides details about the discussion group. 
 
If after reading the Information Sheet you would like to take part in the discussion group, 
please fill in the Consent Form enclosed with this letter and bring this along with you on the 
day. 
 
We would appreciate your attendance at the discussion group. This will help professionals to 
gain a better understanding of the things that are important to consider from the point of view 
of carers and relatives.  The details of the discussion group are as follows: 
 





Research Assistant, Partnerships in Care 
  
APPENDIX 4




NIHR Health Services and Delivery Research Programme. Project 13/114/37: Outcomes 
from forensic services for people with intellectual and developmental disabilities: 
evidence synthesis and expert and patient consultation 
 
We are writing to you to invite you to take part in a discussion group. This discussion group is  
part of the above named research project which is funded by the National Institute for Health 
Research. Please take time to read the following information carefully. 
 
What is the discussion about? 
The discussion group will be a group of 6-8 carers, relatives or friends of people who are 
currently using forensic learning/intellectual disability services at St. John’s House. 
 
Why is the discussion group taking place? 
Although there has been some research into how well these types of services in hospitals are 
doing at helping people, the views of families/carers has not been widely considered in this 
research. We are interested in holding a discussion group so that we can gain the opinions of 
carer’s/families. 
 
What is the aim of the discussion? 
The purpose of the discussion is to explore the outcomes that are important and relevant from 
the point of view of people who are family, friends, relatives or carers for the people using the 
learning/intellectual disability service at St. John’s House. 
 
What is an Outcome? 
An outcome is a change that happens to someone as a result of them staying in hospital for 
treatment. 
 
What will I have to do? 
We would like to talk to you about the future of the people you care for who are using the 
service. We want to know what you want to happen for them after being in the current service 
and after secure care. Whilst we will ask you a few questions, the group will be an open 
discussion as we are interested in your thoughts and opinions on the topic. 
 
What happens on the day? 
You will be invited to come to St. John’s House on Friday 29th May 2015. The group will last 
for approximately one hour. The project leader and a research assistant will ask you some 
questions to gather your opinions. They may write down the ideas that you say.  
 
What are the benefits of attending? 
We are able to provide payment of £120 per person for those who are able attend. Travel 
expenses will also be provided at 45 pence per mile.  
 
Listening to the views of relatives and carers can also be important so that professionals are 
able to include these views in future research. It is also hoped that this will help to improve 
the way that services measure changes (outcomes) for patients. 
 
What will happen to the information? 
Your name will not be written down so that the discussion remains confidential. The 
discussion will be typed up. The transcript will only be read and used by the project lead and 
research assistant.  
 
How will the information be used? 
We are planning a future research project on finding out what happens to people after secure 
care. We want to  
hear both from patients themselves and carers or family members too. What you say will help 
us with this research. 
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Who do I contact for more information? 







If you would like to take part please read through the attached consent form. If you are happy 
to do so, please sign and date the form. 
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Appendix 5 Topic guides for consultation groups
NIHR CRG-FIDD Project HSDR 13114/37 
Outcomes from Forensic Services for People with Intellectual and Developmental 
Disabilities:  
Evidence Synthesis and Expert and Patient Consultation 
 
Stage 2: Patient Involvement/Consultation: Patient group topic guide  
 
Preamble 
We are going to talk to you about your future. We want to know what you want to happen 
after  secure care. This might be quite difficult to think about. There are no right or wrong 
answers. We are interested in your thoughts and feelings.  
 
We are talking to patients about this because we are doing research on finding out what 
happens to people after secure care. What you say will help us with this research. 
 
If you would like to take part please read through the consent form. If you are happy, please 
sign the consent form and write today’s date on it. 
 
 
I have a list of the sort of things that doctors, psychologists and researchers tend to look at 
when we think about treatment outcomes. I will start us off, but please contribute with any of 
your thoughts or suggestions. 
 
Priorities and Expectations 
• How do you want to change while you are in treatment in this hospital? 
• What are the most important or the main changes your team should look for? 
 
Change 
• How have you changed from when you arrived at the hospital?  
• What things are different now? (how you feel, how you talk to people, therapy you 
do) 
• Is there anything you do more of? 
• Is there anything you do less of? 
• What has helped you to make changes? 
 
Progress 
• What things help you to feel better? 
• What things help you move forward? 
• How do you know when you are doing better? 
• What should the team look at to see if you are getting better?  
• How do you know when you are doing well? 
 
Goals 
• What are your goals? 
• Where would you like to be in 1 year? 
• Where would you like to be in 5 years? 
 
Relationships 
• What do your families want for you in the future? 
• What do your family see is a sign that you are getting better? 
• Would you like to have a partner (or children)? 
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Employment 
• Is it important to get a job? What kind of work would you like to do? 
• Would you like to go to college? What training would you like to have? 
 
Living/Support/ Community 
• Where would you like to live after you leave secure care? 
• Who would you like to live with? (Family, friends, on your own, partner, staffed 
/unstaffed?) Why? 
• What do you need support or help with? 
• What type of support would you like in the future? 
• How do you know when you are independent and doing things for yourself? 
• Do you think it is important to have less support from people as you get better?  
 
Mental Health 
• How do you know when your mental health is better? 
• Has the way you talk about your feelings changed? Is this important to you? 
• Is medication important? 
• Has the way you speak to people changed?  
• Has the way you act around people changed?  
• What about self-harm? Is this something you can talk about? How has this changed? 
 
Adaptive Skills 
• How much support will you need when living in the community? (prompt: 24 hour, 
few hours a day) 
• Is it important to be in charge of your own money? 
• Is it important to be able to look after yourself (cooking, washing, shopping)? 
• How important is not using drugs and alcohol? 
 
Safety 
• Do you feel safe? What about things that happen to you here that you don't like?  
• What things would you want to happen to you less often? (P) Seclusion, restraint 
things like that? Would you like to be secluded less? What about being restrained? 
What should people do instead?  
• Are you happy with your medication? Would you like to have more or less 
medication or PRN? If you were using that less often would it mean you were getting 
better? 
• Bullying by other patients/or assault by other patients?  
• Does that happen - would you like it to happen less? 
• PRN or medication - would you like to have more or less medication? If you were 
using that less often would it mean you were getting better? 
• What would help you to keep out of trouble when you are in the community? 
Final Question: 
 
Of all the outcomes from treatment in hospital we have discussed what is the most important 
for you? (Ask each person) 
 
Is there anything else you would like to say about your life after secure care? 
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Close 
Talking about these issues can be difficult. If talking about you and your future has made you 
feel unhappy please speak to staff. Talking to you has been really helpful. Thank you for 
taking part. 
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NIHR CRG-FIDD Project HSDR 13114/37 
Outcomes from Forensic Services for People with Intellectual and Developmental 
Disabilities:  
Evidence Synthesis and Expert and Patient Consultation 
 
Stage  2: Patient/Carer Involvement /Consultation 
 
Carer Group: Topic guide 
 
Preamble 
We are going to talk to you about the future of the people you care for who are using the 
service. We want to know what you want to happen for them after being in the current service 
and after secure care. This might be quite difficult to think about. There are no right or wrong  
answers. We are interested in your thoughts and opinions. 
 
The questions are about outcomes. An outcome is a change that happens to someone as a 
result of being in the hospital and receiving support. 
 
We are planning a research project on finding out what happens to people after secure care. 
We want to hear both from patients themselves and carers or family members too. What you 
say will help us with this research. 
 
If you would like to take part please read through the consent form. If you are happy to do so, 
please sign the consent form and write today’s date on it. 
 
 
Priorities and Expectations 
• What are your expectations for the person you care for? 
• What are the priorities (important or main changes) for looking at outcomes for the 
person you care for? 
 
Change 
• How has the person you care for changed from when they first arrived at the 
hospital?  
• What things are different now? 
• Is there anything they do more of? 
• Is there anything they do less of? 
• What do you think has helped them to make changes? 
 
Progress 
• What things have helped them to feel better? 
• What things have helped them to move forward? 
• How do you know when the person you care for is doing better? 
• From your point of view, what should the team look at to see if the person you care 
for is getting better?  
 
Needs 
• What are the outcomes (positive changes) that you think should be looked at for the 
person you care for? 
• What about outcomes for yourself? 
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Goals 
• Where would you like the person you care for to be in 1 year? 
• Where would you like the person you care for to be in 5 years? 
• Do you have any other goals for this person? 
 
Employment 
• Would you like them to have a job? What kind of work? 
• Would you like them to go to college?  
• What kind of training would you like them to have? 
 
Living/Support 
• Where would you like them to live after secure care?  
• Who would you like them to live with? 
• What type of support would you like them to have in the future? 
• What might they need support or help with? 
• Do you think it is important that the person you care for has less support from people 
as they get better or will they always need support?  
 
Mental Health 
• How do you know when their mental health has improved? 
• Has the way they talk about their feelings changed? Is this important? 
• Has the way they speak to people changed? Is this important? 
• Is medication important? 
 
Adaptive Skills 
• How much support do you think they will need in the future? (e.g. 24 hour, few hours 
a day) 
• Is it important for them to be in charge of their own money? 
• Is it important that they are able to look after themselves (cooking, washing, 
shopping)? 
• How important is not using drugs and alcohol for the person you care for? 
 
Is there anything else you would like to say about their life after secure care? 





Talking about these issues can be difficult. If talking about the person you care for and their 
future has made you feel unhappy please contact one of the research team. Talking to you has 
been really helpful. Thank you for taking part. 
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Appendix 6 Delphi information sheet and
round 1 questionnaire
Outcome domains for services for people with intellectual and developmental disabilities  
 
NIHR Health Services and Delivery Research Project 13/114/37 
 
Information Sheet 
As a clinical or commissioning expert in the field of Forensic Intellectual and Developmental Disability 
(FIDD) we would like to invite you to take part in a Delphi consensus study. Before you decide 
whether or not you would like to take part, it is important to consider why the research is being done 
and what it will involve. Please read this information sheet carefully. 
 
What is the purpose of the study? 
Relatively little is known about outcomes from forensic intellectual developmental and disability 
(FIDD) services, other than from a small number of single site studies. This study is part of the scoping 
phase of a future longitudinal research project on outcomes from FIDD services, which would include 
secure and less secure services and specialist community forensic ID services for people with ID and 
ASD.  This study aims to develop an expert consensus on which are the most appropriate outcome 
domains and indicators for use in future evaluation of such services.  This would include outcomes 
which relate both to what happens to patients as a result of their care in such services, and aspects of 
the quality of care in services. We are interested in your views on the important domains and on how 
these are best measured.  
 
What is a Delphi study? 
The Delphi technique seeks to generate a level of agreement on a particular topic based on the opinions 
of experts. This is an iterative process designed to combine opinion into group consensus.  
 
For the purposes of this study this will be a two-stage process. In round one, you will be asked to 
provide responses and ratings to a series of questions. The responses are collated, summarised and fed 
back in round two. During the second round you will have the opportunity to respond to the questions 
again. It is important that you complete both rounds. 
 
All responses received in the study will be strictly confidential. Direct quotes from free text answers 
may be used as part of the study report or later Delphi iterations, but these will be anonymised and 
therefore not traceable back to you. 
 
Findings will inform the future wider project and will also be disseminated to FIDD services, 
commissioners, researchers, and patients to inform current clinical practice. 
 
Who is organising and funding the research? 
This research is part of a National Institute for Health Research (NIHR) funded research project 
examining outcomes for FIDD services. The Delphi study will be led by Dr. Catrin Morrissey, 
Principal Investigator. The research advisory team include Dr Regi Alexander, Dr Jayne McCarthy, Dr 




No personal information will be collected and survey responses will be collated anonymously. All 
responses received in the study will be strictly confidential, and your identity will not be divulged. 
Direct quotes to free text answers may be used as part of the study report or later Delphi iterations, but 
these will be anonymised and therefore not  
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Data protection 
Survey responses will be collected online. Results will be downloaded to an encrypted Nottinghamshire 
Healthcare NHS Foundation Trust computer to allow analysis by the research team, using a participant 
identifying number known only to the research assistant. Data will be stored for the duration of the 
research project only and then deleted. You have the right to access submitted information according to 
UK data protection laws. 
 
Governance 
The proposed study has been reviewed by the Nottinghamshire Healthcare NHS Foundation Trust 
Research and Development Department.  
 
What do I do now? 
Thank you for reading this information sheet and for considering taking part in this research. If you are 
happy to proceed, read the instructions and proceed to complete the survey. If you have any questions 
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Instructions       
 
• This survey is part of the scoping phase of a project relating to outcomes from forensic 
intellectual and developmental disability (FIDD) services. These services include those for 
people with ASD with or without intellectual disabilities. 
 
• We are aiming to identify which outcome domains and indicators should be a priority for 
FIDD service evaluation. This relates to evaluating both the progress of patients treated in 
such services (both in the short and longer term i.e. during treatment in hospital and post 
discharge) and for evaluating the quality of care in such services as a whole.  
 
• We are therefore consulting experts for their views on the areas of greatest importance 
and highest priority.  The aim is to develop a consensus on which indicators should be 
included in a future longitudinal study of such services, and could potentially be utilised as 
common outcome indicators across such services. The three overarching domains of 
interest are those identified in the NHS Outcomes Framework - Effectiveness, Patient 
Safety and Patient Experience.  However there are many potential sub-domains within 
these three areas. We are interested both in your views on the most important domains 
and on how these are best measured.  
 
• The domains, sub-domains and indicators listed below have been identified from a 
systematic review of the literature in this area in June 2015 and from consultations with 
patients and carers conducted in June 2015. 
 
• There are five parts to this questionnaire; please complete all five sections. It should take 
no longer than 10-15 minutes 
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Part One: Background Information 
 




 Other …………………….. 
Area of Work 




 Other …………………………… 
Number of years working in 
/researching/commissioning Forensic 
Intellectual Disability Services 
 
___ years 
Type of service currently working in (tick 
all that apply) 
 High Secure 
 Medium Secure 
 Low Secure 
 Community 
 Locked Rehabilitation 
 Non-Secure LD, ID or ASD service 
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Part Two: Effectiveness          
 
Please rate how important you think the following outcome domains/indicators are for evaluation of 
forensic intellectual and developmental disability (FIDD) services. A key is provided below; ratings are 
made from 1 to 5. 
IMPORTANCE/PRIORITY  
1 2 3 4 5 
Not at all important Slightly 
Important  






• Not important or 
appropriate outcome 
domain for FIDD 
services 
• Not a priority 
•  Slightly important 
and appropriate 
outcome domain for 
FIDD services 
• A low priority 
Neutral as to whether 
it is important or 
appropriate  for FIDD 
services 
•  Important and 
appropriate  
outcome domain for 
FIDD services   
• A priority 
• Highly important  
and appropriate 
outcome domain for 
FIDD services 






(1 to 5) 
Preferred 
Measures/Indicators  
Length of hospital stay   
Delayed discharge/ Current placement 
appropriateness 
  
Discharge outcome/ direction of care pathway 
(i.e. did the patient move to a lower level of 
therapeutic security/non hospital setting ) 
  
Re-admission (i.e. was the patient readmitted 
within a specified time period?) 
  
Treatment response/engagement   
Clinical symptom severity /treatment needs – 
patient rated 
  
Clinical symptom severity – clinician rated    
Adaptive functioning   
Incidents (violence/self-harm)   
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Re-offending (charges/reconvictions)   
‘Offending-like’ behaviour (i.e. behaviour 
which did not results in charges) 
  
Security need  (e.g. physical/ 
procedural/escort/leave) 
  
Risk assessment measures   
Recovery measures/progress on treatment 
goals – patient rated 
  
Recovery measures/progress on treatment 
goals – clinician rated 
  
 
Please specify any additional outcome domains or indicators which you consider important from 
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Part Three: Patient Safety 
 
Please rate how important you think the following outcome domains/indicators are for the evaluation 
of forensic intellectual disability services. A key is provided below, ratings are made from 1 to 5. 
IMPORTANCE 
1 2 3 4 5 
Not at all important Slightly 
Important  






• Not important or 
appropriate for FIDD 
services 
• Not a priority 
•  Slightly Important 
and appropriate for 
FIDD services 
•  
 Low priority 
 
Neutral as to whether 
it is important or 
appropriate  for FIDD 
services 
•  Important and 
appropriate  for 
FIDD services 
   
• A priority 
• Highly appropriate 
and important  for 
FIDD services 
• High priority  
 
Patient Safety  
 IMPORTANCE 
(1 to 5) 







Death/Suicide   
Victimisation/safeguarding   
Medication (e.g PRN/ 
exceeding BNF) 
  
Physical health   
 
Please specify any additional outcome domains or indicators which you consider important from 
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Part Four: Patient Experience  
Please rate how important you think the following outcome domains/indicators are for the evaluation 
of forensic intellectual disability services. A key is provided below, ratings are made from 1 to 5. 
 
IMPORTANCE/PRIORITY  
1 2 3 4 5 
Not at all important Slightly 
Important  






• Not important or 
appropriate outcome 
domain for FIDD 
services 
• Not a priority 
•  Slightly important 
and appropriate 
outcome domain for 
FIDD services 
• A low priority 
Neutral as to whether it 
is important or 
appropriate  for FIDD 
services 
•  Important and 
appropriate  
outcome domain 
for FIDD services   
• A priority 
• Highly important  
and appropriate 
outcome domain for 
FIDD services 
• High priority  
 
 
Patient Experience  
 IMPORTANCE 
(1 to 5) 
Preferred Measures 
Quality of Life (patient 
rated) 
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Please specify any additional outcome domains or indicators which you consider important from 
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Part Five: Top Outcome Domains 
 
Please select up to five outcome domains which, in your opinion, are the most important/highest 
priority for the routine evaluation of forensic intellectual disability services. I.e. if services had to 
collect only five outcome indicators which would they be? 
 



















Thank you for completing the Delphi Exercise. The second stage will be e-mailed to you in 2 
weeks time. 
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Appendix 7 Delphi round 2 questionnaire
Round Two 
 
Thank you for taking part in the first round of this Delphi exercise. This is the second and final 
round. Please read these instructions carefully: 
 
We are interested in your views on the most important/highest priority outcome domains. The aim of 
this Delphi is to develop a consensus on which sub-set of indicators should be included in a future 
longitudinal study of such services, and could potentially be utilised as common outcome 
indicators across such services. 
• There are two parts to this questionnaire. Firstly, please review and rate the importance of each 
sub-domain using the scale provided. There are 31 items to rate. 
• Secondly, please select up to five sub-domains which you perceive to be the most 
important/highest priority.  
• You will see two columns next to each subdomain in both sections. The middle column shows the 
group response and the right-hand column is blank and is provided for you to reconsider your 
original response in the context of the group response from the previous round. 
• Your ratings from Round One are supplied as a PDF attachment to email invitation. You do not 
have to change your answer if you do not wish to do so. 
• Please complete both sections. It should take no longer than 10 minutes. 
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Section Two: Rating of Outcome Domains 
 
Please rate how important the following outcome domains are for evaluation of forensic intellectual 
and developmental disability (FIDD) services.  
• Please provide a new rating in the right-hand column Ratings are made from 1 (not important) 
to 5 (extremely important).  
• Your original ratings are attached to your email invitation (Sections 3, 4 and 5).  
• The average group score from Round One is presented in the middle column.  
• You do not have to change your response from your original answer if you do not wish to. 
 
1 






















 Not a priority 







 A low priority 
Neutral as to 





















 A high priority 
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Effectiveness Average Rating 
Your 
Rating 
Length of hospital stay 3.65  
Delayed discharge/current placement appropriateness 4.24  
Discharge outcome/direction of care pathway (i.e. the patient moves to 
a lower level of therapeutic security/non hospital setting) 4.53 
 
Re-admission (i.e. the patient is readmitted within a specified time 
period) 4.00 
 
Treatment response/engagement 4.65  
Clinical symptom severity /treatment needs – patient rated 4.24  
Clinical symptom severity/treatment needs – clinician rated 4.41  
Adaptive functioning 3.82  
Incidents (violence/self-harm) 4.29  
Re-offending (charges/reconvictions) 4.59  
‘Offending-like’ behaviour (i.e. behaviour which did not result in 
charges) 4.47 
 
Security need (i.e. physical/procedural/escort/leave) 3.94  
Risk assessment measures 4.35  
Recovery measures/progress on treatment goals – patient rated 4.53  
Recovery measures/progress on treatment goals – clinician rated 4.47  
Patient Safety 
Restrictive practices (i.e. seclusion/segregation) 4.29  
Restrictive practices (i.e. restraint) 4.29  
Premature death and suicide 4.59  
Victimisation/safeguarding 4.53  
Medication (i.e. PRN/ exceeding BNF prescribing limits) 4.24  
Physical health 4.12  
Patient/Carer Experience 
Quality of Life - patient rated 4.59  
Quality of Life - clinician rated 3.94  
Patient experience: satisfaction/complaints 4.29  
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Patient experience: involvement 4.41  
Carer experience: communication 4.18  
Carer experience: involvement 4.06  
Therapeutic Milieu 4.41  
Closeness to ‘home’ area 3.59  
Involvement in community (where appropriate) 4.35  
Access to work/meaningful activity (where appropriate) 4.65  
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Section Two: Top Five Outcome Domains 
 
In Round One, you selected up to 5 outcome domains which were the most important/highest priority 
for the evaluation of forensic intellectual disability services.  
In the right-hand column, use the checkbox provided to select up to 5 sub-domains which are, in your 
opinion, the most important and of the highest priority.  
The items you originally endorsed as being the most important (‘top 5’) are attached (question 6).  
The percentage of respondents who endorsed each sub-domain as one of their top five most important 
outcomes is presented in the middle column.  
You do not have to change your response from your original answer if you do not wish to. 
 
 
Effectiveness %  
Length of hospital stay 24  
Delayed discharge/current placement appropriateness 18  
Discharge outcome/direction of care pathway 41  
Re-admission (i.e. the patient is readmitted within a specified time period) 18  
Treatment response/engagement 47  
Clinical symptom severity/treatment needs 70  
Adaptive functioning 24  
Incidents (violence/self-harm) 18  
Re-offending (charges/reconvictions)/ ‘Offending-like’ behaviour 59  
Security need (i.e. physical/procedural/escort/leave) 12  
Risk assessment measures 41  
Recovery measures/progress on treatment goals  41  
Patient Safety  
Restrictive practices (i.e. seclusion/segregation/restraint) 12  
Premature death and suicide 12  
Victimisation/safeguarding 1  
Medication (i.e. PRN/ exceeding BNF prescribing limits) 12  
Physical health 1  
Patient Safety in general 12  
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Patient/Carer Experience  
Quality of Life 12  
Patient experience 24  
Carer experience 0  
Therapeutic Milieu 6  
Closeness to ‘home’ area 0  
Involvement in community (where appropriate) 0   
Access to work/meaningful activity (where appropriate) 24  
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Appendix 8 Provisional ‘long list’ of
measures/indicators
Effectiveness domain Measure/indicator (individual-/patient-level data)
Direction of care pathway (compared with
12 months ago)
% of patients who (compared with 12 months ago) are
l in higher level of security hospital/prison
l in same level of security hospital
l in lower level of security hospital
l discharged to community
l in prison





Living arrangement and level of support
Readmitted (community) For those discharged to community:
l ever readmitted: yes/no
l number of bed-days in past 12 months
l number of prison-days in past 12 months
Length of hospital stay Date of hospital admission – current date. If discharged, length of stay on
discharge date
Clinical symptoms (patient rated) Clinical Outcomes Routine Evaluation – LD (total score) (12-item outcome
measure validated on intellectual disabilities)




Team rating, for example:
l good (making good progress on treatment goals and well engaged)
l fair (mixed progress or static)
l poor (regression: disengagement or negative progress in relation to
treatment goals)
Or
l HCR-20-V3 item C5
l treatment responsiveness measure (to be designed)
l Camberwell Assessment of Needs for Adults with Developmental and
Intellectual Disabilities measure (need)
Specific treatment goal measure (My Shared Pathway or similar)
Recovery/engagement/progress on treatment
goals: (patient/carer rated)
Parallel ratings to be developed
Adaptive functioning HoNOS-secure rating (item 10)




HCR-20-V3 clinical items total
HoNOS-secure rating A (risk of harm)
DOI: 10.3310/hsdr05030 HEALTH SERVICES AND DELIVERY RESEARCH 2017 VOL. 5 NO. 3
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Morrissey et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
97
Effectiveness domain Measure/indicator (individual-/patient-level data)
Incidents Mean number contact violent/sexual incidents per month of inpatient stay
(past 12 months) (agreed definition required)
Mean severity of incidents (past 12 months)
Each incident coded, for example:
1. high risk of harm to others
2. medium risk of harm to others
3. low risk of harm to others
Mean self-harm incidents per month (past 12 months) (agreed definition
required)
Mean severity of incidents (past 12 months)
Each incident coded:
1. high risk of harm to self
2. medium risk of harm to self
3. low risk of harm to self
Level of security appropriate to current
needs
HoNOS-secure item C (compared with actual level)
OR
Security, Dependency and Treatment Needs scale
Reoffending (community) In past 12 months:
l number of arrests (police records)
l number of charges (police records)
l number of convictions (criminal records)
Offence-like behaviour (community) In past 12 months:
Number of incidents using same definition of ‘incident’ as for inpatient
(service or carer records using structured format)
Patient safety domain Measure/indicator (service-level data)
Premature death/suicide Number of premature/unexpected deaths (past 12 months) (as NHS
Outcomes Framework)
Reason code
Physical health HoNOS-secure item B (mean for service)
HoNOS-LD (if community)
Self-harm Self-harm incidents (12 months)
Medication Number of patients exceeding BNF limit (past 12 months)
Number of PRN episodes (past 12 months)
Medication (patient rating) Patient survey rating with pictorial rating, for example:
l my medication makes me feel worse
l my medication does not make me feel better or worse
l my medication makes me feel better
Or LUNSERS measure
Seclusion Mean number of seclusion episodes per inpatient month (past 12 months)
Or
Number of episodes per month per 10 inpatient beds (see NHS
benchmarking)
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Effectiveness domain Measure/indicator (service-level data)
Restraint Mean number of restraints per inpatient month (past 12 months)
Or
Number of restraints per month per 10 inpatient beds (see NHS
benchmarking)
Victimisation/SG Number of patient on patient assaults recorded (past 12 months)
HoNOS-secure scales item F
Patient survey rating, for example:
% of patients who endorse ‘I feel safe and secure in this service’
Patient/carer experience domain
Measure/indicator (all rated once in a 12-month period)
(service-level data)
Patient complaints Mean number of patient generated complaints per inpatient month
Patient involvement Patient survey rating with pictorial rating, for example:
l I feel my team involve me a lot in my own care
l I feel my team involve me a bit in my own care but I would like to be
more involved
l I feel my team do not involve me in my care
(Or CTR rating achieved?)
Quality of life MANS–LD or European Quality of Life-5 Dimensions
Stability: number of home moves in past
12 months (community)
Number of home moves
Access to work and meaningful engagement Mean number of hours meaningful activity per patient per week
% in paid work (community) (see NHS Outcomes Framework83)
Carer experience
Involvement Carer survey rating, for example (% rating ‘enough’ involvement):
l I feel my team involve me enough in my relative’s care
l I feel my team involve me in my relative’s care but I would like to be
more involved
l I feel my team do not involve me in my relative’s care
Communication Carer survey rating, for example (% carers rating good communication):
l I feel there is good communication between the carer and the
care team
l I feel there is adequate communication between the carer and the
care team
l I feel there is poor communication between the carer and the
care team
Therapeutic climate Friends and Family Test (% who would recommend service)
At least 50% sample staff EssenCES within 12-month period
At least 50% sample patient EssenCES (intellectual disabilities adapted)
within 12-month period
Mean total score on three EssenCES subscales
Level of support (patient-rating) Patient/service user survey rating, for example (% rating good support):
l I feel I have good support
l I feel I would like a bit more support
l I feel I would like a lot more support
DOI: 10.3310/hsdr05030 HEALTH SERVICES AND DELIVERY RESEARCH 2017 VOL. 5 NO. 3
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Morrissey et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
99
Effectiveness domain Measure/indicator (service-level data)
Level of support (carer-rating) (% rating good support)
l I feel I/my relative has good support
l I feel I/my relative would like a bit more support
l I feel I/my relative would like a lot more support
Social network (community) Social Network Guide (Tizard Centre 2006, personal communication)
BNF, British National Formulary; CTO, Community Treatment Order; CTR, Care and Treatment Review; HCR-20-V3, Historical,
Clinical Risk 20 version 3; LUNSERS, Liverpool University Side Effects Rating Scale; MANS-LD, Maslow Assessment of Needs
Scales - Learning Disabilities; SG, safeguarding.
Notes
Clinical background variables to be coded, for example: diagnoses; Wechsler Adult Intelligence Scale – IV; criminal history;
MHA section; initial level of security, etc.
For most effectiveness variables change on the variable is to be measured, so the final indicator will need to be a summary
rating of within-patient change. For example, (in past 12 months):
l % patients who increased score on item (got worse)
l % patients who reduced score on item (improved)
l % patients with unchanged score (no change).
It will be important to consider parallel indicator items from the NHS Outcomes Framework, Adult Social Care Outcomes
Framework and Mental Health and Learning Disability minimum data set when appropriate.
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Appendix 9 Summary of research for public and
patient involvement dissemination
Health Services and Delivery Research Programme research
project 13/114/37
What happens to people who are in secure services for people with intellectual and
developmental disabilities?
Looking at the previous research and consulting with patients in hospital, their carers and their clinicians.
What we wanted to do
l We are a group of researchers who work in different secure services.
l This is a report on some work we did in 2015.
l We want to know what happens when patients with IDD are in secure hospital and after hospital.
We call this ‘outcomes’.
l We want to know things like: how do they change, where do they end up and what support do they
get later on?
l This small piece of work was part of planning our next big research project, which will take 5 years.
l Because it will be a big project we want to do it properly.
l So we want to know what questions to ask, what things are important to measure and how to
measure them.
l To help to decide this we looked at work by other researchers, and we talked to secure patients and
carers, and their doctors, nurses and psychologists.
l We wanted to find out to find out what these people thought we should look at when we are doing
our big research project.
l The work was paid for by the NIHR.
What we did
l We looked carefully at 60 studies from around the world.
l We talked to 11 patients and six carers and 15 clinicians.
l We put all this information together.
What we decided
The main three areas we decided we should look at in future research were:
1. Does secure hospital treatment make people better?
2. How safe are patients in hospital?
3. What is hospital like for patients and their carers? And what is their experience on discharge
from hospital?
We will talk about each of these.
1. Does secure hospital treatment make people better?
The conclusions were that in our next research the most important things to measure are:
i. How peoples’ mental health symptoms change and how patients see that change.
ii. Whether people are reaching their goals for treatment and how patients see their progress.
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iii. How peoples’ behaviour changes (e.g. do they harm others or themselves any less often?).
iv. Whether people do actually commit offences or harm others when they come out of hospital.
v. How people move through the hospital system and how fast do they do that?
2. How safe are patients in hospital?
The conclusions were that in our next piece of research we should look at:
i. How often people are secluded or restrained?
ii. How many people feel they are on too much medication?
iii. How many people died or took their own life?
iv. How often other patients are harmed by other patients?
3. What is hospital like for patients and their carers and what happens on discharge?
The conclusions were that in our next research project we should look at:
i. How satisfied patients are with their care?
ii. How satisfied carers are with their care?
iii. How involved patients and carers feel in the care – do they have a say?
When they leave hospital:
i. Where do people go?
ii. How much support do people get when they leave hospital?
iii. How involved they are in the community?
iv. Whether patients have enough to do in hospital and after hospital.
v. Do they go back to hospital or prison?
We have suggested ways to measure all these things.
We plan to apply for funding from NIHR to collect information on ALL people with LDs and autism who go
through secure hospitals. We want to describe their characteristics in detail and to see what happens to
them over 5 years. We want to know what happens both while they are in hospital and after hospital.
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